Document:

Amended and Restated Registration Rights Agreement

 Exhibit 10.9 
 EXECUTION COPY 
 AMENDED AND RESTATED 
 REGISTRATION RIGHTS AGREEMENT 
 THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”)
is made as of this 27th day of May, 2004, by and among Medidata Solutions, Inc., a Delaware corporation (together with any successor thereto, the
“Company”), and the investors listed under the heading “Investors” on the signature pages hereto, including the investors of the Series D Preferred Stock (as defined below) (the “Series D Investors”) and
any other investor who from time to time becomes a party to this Agreement by execution of a Joinder Agreement in substantially the form attached as Exhibit I hereto (each, an “Investor” and collectively, the
“Investors”). 
 R E C I T A L S : 
 WHEREAS, the Company entered into that certain Registration Rights Agreement dated as of January 25, 2002 by and among the Company and the
investors signatory thereto, as amended by Amendment No. 1 to the Registration Rights Agreement dated as of February 25, 2003 (the “Prior Registration Rights Agreement”); and 
 WHEREAS, the Company and the Series D Investors are concurrently entering into a certain Securities Purchase Agreement, dated as of the date
hereof (the “Purchase Agreement”), pursuant to which the Series D Investors have agreed to purchase shares of Series D Convertible Redeemable Preferred Stock, $0.01 par value per share (the “Series D Preferred
Stock”), from the Company in accordance with the terms and conditions contained therein; and 
 WHEREAS, the execution of
this Agreement is a condition precedent to the purchase by the Series D Investors of the Series D Preferred Stock under the Purchase Agreement; and 
 WHEREAS, the parties to the Prior Registration Rights Agreement desire to amend and restate the Prior Registration Rights Agreement and to accept the rights and covenants hereof in lieu of their rights and covenants under the Prior
Registration Rights Agreement; and 
 WHEREAS, the amendment and restatement to the Prior Registration Rights Agreement has been
effected in accordance with Section 9(a) of the Prior Registration Rights Agreement by the written consent of the Company and the holders of at least a majority of the outstanding Registrable Securities (as defined below). 
 NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements hereinafter set forth, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 
 1. Certain
Definitions. As used in this Agreement, the following terms shall have the following respective meanings: 
 An
“Affiliate” of any Person means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with the first mentioned Person. A Person shall be deemed to
control another Person if such first Person 

 
possesses directly or indirectly the power to direct, or cause the direction of, the management and policies of the second Person, whether through the
ownership of voting securities, by contract or otherwise. 
 “Agreement” shall have the meaning set forth in the
recitals hereto. 
 “Commission” shall mean the United States Securities and Exchange Commission, or any other
federal agency at the time administering the Securities Act and the Exchange Act. 
 “Common Stock” shall mean the
Company’s Common Stock, $0.01 par value per share, as authorized on the date of this Agreement and any other common equity securities now or hereafter issued by the Company, and any other shares of stock issued or issuable with respect thereto
(whether by way of a stock dividend or stock split or in exchange for or in replacement of or upon conversion of such shares or otherwise in connection with a combination of shares, recapitalization, merger, consolidation or other corporate
reorganization). 
 “Controlling Person” shall have the meaning set forth in Section 5(a). 
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, or any similar successor federal statute, and the
rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
 “Group” shall
mean: 
 (a) in the case of any Investor who is an individual, (i) such Investor, and (ii) the spouse, parents, siblings or
descendants of such Investor; 
 (b) in the case of any Investor that is a partnership, (i) such Investor, (ii) its limited,
special and general partners, (iii) any Person to which such Investor shall transfer all or substantially all of its assets, and (iv) all Affiliates and employees of and consultants to, such Investor or any of its Affiliates; and

 (c) in the case of any Investor which is a corporation or a limited liability company, (i) such Investor, (ii) its Investors or
members as the case may be, (iii) any Person to which such Investor shall transfer all or substantially all of its assets, and (iv) all Affiliates of such Investor; 
 “Holders” shall have the meaning set forth in Section 2(a) hereto. 
 “Investor” shall have the meaning set forth in the recitals hereto. 
 “Person” shall mean an individual, a corporation, a partnership, a joint venture, a trust, an unincorporated organization, a
limited liability company, a government and any agency or political subdivision thereof. 
 “Prior Registration Rights
Agreement” shall have the meaning set forth in the recitals hereto. 
  

 2 

 “Purchase Agreement” shall have the meaning set forth in the recitals hereto.

 “Registrable Securities” shall mean (i) any shares of Common Stock held by an Investor, (ii) any shares
of Common Stock subject to acquisition by an Investor upon conversion of any securities of the Company held by such Investor that are convertible into or exercisable or exchangeable for Common Stock, and (iii) any other securities issued and
issuable with respect to any such shares described in clauses (i) and (ii) above by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization (it
being understood that for purposes of this Agreement, an Investor will be deemed to be a holder of Registrable Securities whenever such Investor has the right to then acquire or obtain from the Company any Registrable Securities, whether or not such
acquisition has actually been effected); provided, however, that notwithstanding anything to the contrary contained herein, “Registrable Securities” shall not at any time include any securities (A) registered and sold
pursuant to the Securities Act, (B) sold to the public pursuant to Rule 144 promulgated under the Securities Act or (C) which could then be sold in their entirety pursuant to Rule 144(k) without limitation or restriction. 
 “Securities Act” shall mean the Securities Act of 1933, as amended, or any similar successor federal statute, and the rules and
regulations of the Commission thereunder, all as the same shall be in effect at the time. 
 “Selling Holder” shall
have the meaning set forth in Section 5(a) hereto. 
 “Series B Preferred Stock” shall mean the
Company’s Series B Convertible Redeemable Preferred Stock, par value $.01 per share. 
 “Series C Preferred
Stock” shall mean the Company’s Series C Convertible Redeemable Preferred Stock, par value $.01 per share. 
 “Series D Investors” shall have the meaning set forth in the recitals hereto. 
 “Series D
Preferred Stock” shall have the meaning set forth in the recitals hereto. 
 “Stockholders Agreement”
shall mean that certain Second Amended and Restated Stockholders Agreement, dated as of the date hereof, among the Company and the stockholders signatory thereto. 
 2. Piggyback Registrations. 
 (a) If at any time or times after the date hereof (other than in
connection with the Company’s initial public offering) the Company shall seek to register any shares of its Common Stock under the Securities Act for sale to the public for its own account or on the account of others (except with respect to
registration statements on Form S-4, Form S-8 or another form not available for registering the Registrable Securities for sale to the public and except with respect to registration statements filed pursuant to Section 3 hereof, which
shall be governed by said Section 3), the Company will promptly give written notice thereof to all holders of Registrable Securities (the “Holders”). If within twenty (20) days after their receipt of such notice one
or more Holders request the inclusion of some or all of the Registrable Securities 

  

 3 

 
owned by them in such registration, the Company will use its reasonable best efforts to effect the registration under the Securities Act of such Registrable
Securities. In the case of the registration of shares of capital stock by the Company in connection with any underwritten public offering, if the underwriter(s) determines that marketing factors require a limitation on the number of Registrable
Securities to be offered, then, subject to the following sentence, the Company shall not be required to register Registrable Securities of the Holders in excess of the amount, if any, of shares of the capital stock which the principal underwriter of
such underwritten offering shall reasonably and in good faith agree to include in such offering in addition to any amount to be registered for the account of the Company. If any limitation of the number of shares of Registrable Securities to be
registered by the Holders is required pursuant to this Section 2, the number of shares to be excluded from such registration shall be determined in the following sequence: (i) first, securities sought to be included by any Persons
not having any contractual, incidental “piggyback” rights, (ii) second, securities sought to be included by any Persons (other than the Holders) having contractual, incidental “piggyback” rights pursuant to an agreement
which is not this Agreement, and (iii) third, Registrable Securities sought to be included by the Holders under this Section 2 as determined on a pro rata basis (based upon the respective holdings of Registrable Securities by such
Holders). 
 (b) Subject to the provisions contained in this Section 2, in any offering other than an initial public offering,
the number of Registrable Securities requested to be so registered may not be limited to less than 25% of the number of securities to be registered in the total offering. In such case as the offering is limited to less than 25% of the number of
Registrable Securities to be registered in the total offering, the offering will be prohibited. 
 3. Required Registrations.

 (a) Demand Registration. At any time following the earlier of (i) five (5) years after the date hereof or
(ii) 180 days after the date of the closing of the Company’s initial public offering of Common Stock pursuant to an effective registration statement under the Securities Act, on not more than two (2) occasions, the Holders of at
least 30% of the Registrable Securities then held by all holders of Registrable Securities may request that the Company register (pursuant to an underwritten offering, with underwriters reasonably satisfactory to the requesting Holders) under the
Securities Act all or a portion of the Registrable Securities held by such requesting Holders with an anticipated aggregate offering price, before deduction of underwriter discounts and commissions, of at least $2,000,000. Upon receipt of such
request, the Company will use its reasonable best efforts to effect the registration under the Securities Act of such Registrable Securities. With regard to any such registration pursuant to this Section 3(a), if the underwriter(s)
determines that marketing factors require a limitation on the number of Registrable Securities to be offered, then, subject to the following sentence, the number of Registrable Securities to be included in such offering shall be reduced to a number
which the managing underwriter of such underwritten offering shall reasonably and in good faith agree to include in such offering. If any limitation of the number of shares of Registrable Securities to be registered by such Holders is required
pursuant to this Section 3(a), the number of shares to be excluded from such registration shall be determined in the following sequence: (i) first, securities sought to be included by any Persons not having any contractual,
incidental “piggyback” rights, (ii) second, securities sought to be included by any Persons (other than the Holders) having contractual, incidental “piggyback” rights pursuant to an agreement which is not 

  

 4 

 
this Agreement, (iii) third, Registrable Securities sought to be included by the Holders (other than Series D Investors) under this
Section 3 as determined on a pro rata basis (based upon the respective holdings of Registrable Securities by such Holders), and (iv) fourth, Registrable Securities sought to be included by the Series D Investors under this
Section 3 as determined on a pro rata basis (based on the respective holdings of Registrable Securities by such Series D Investors). If the requesting Holders are unable, for any reason, to register 75% of the Registrable Securities so
requested to be registered pursuant to this Section 3(a), such registration shall not be counted as a registration pursuant to this Section 3(a). In any registration pursuant to this Section 3(a) other than the
Company’s initial public offering of Common Stock, the Company may include securities for its own account in such registration only if the managing underwriter so agrees and if the number of Registrable Securities and other securities which
would otherwise have been included in such registration and underwriting will not be limited. 
 (b) Form S-3. After the
Company’s initial public offering of Common Stock registered under the Securities Act, the Company shall use its reasonable best efforts to qualify and remain qualified to register securities on Form S-3 (or any successor form) under the
Securities Act. So long as the Company is qualified to register securities on Form S-3 (or any successor form), the Holders of Registrable Securities shall have the right at any time and from time to time to request registration on Form S-3 (or any
successor form) for the Registrable Securities held by such requesting Holders having an aggregate value of at least $500,000 (based on the then current market price), including registrations for the sale of such Registrable Securities on a delayed
or continuous basis pursuant to Rule 415 under the Securities Act. Such requests shall be in writing and shall state the number of shares of Registrable Securities to be disposed of and the intended method of disposition of such shares by such
requesting holders. 
 (c) Registration Requirements. Following a request pursuant to Section 3(a) or (b) above, the
Company will notify all of the other Holders of Registrable Securities and such Holders shall then have twenty (20) days to notify the Company of their desire to participate in the registration. Thereupon, the Company will use its reasonable
best efforts to cause such of the Registrable Securities as may be requested by such Holders to be registered under the Securities Act in accordance with the terms of this Section 3. If the request for registration contemplates an
underwritten public offering, the Company shall state such in the written notice and in such event the right of any Holder to participate in such registration shall be conditioned upon their participation in such underwritten public offering and the
inclusion of their securities in the underwritten public offering to the extent provided herein, and in their entering into an underwriting agreement in customary form with the underwriter or underwriters for such offering. 
 (d) Postponement. The Company may postpone the filing of any registration statement required hereunder for a reasonable period of time, not to
exceed ninety (90) days in the aggregate during any twelve-month period, if the Company has been advised by legal counsel that such filing would require a special audit or the disclosure of a material impending transaction or other matter and
the Company’s Board of Directors determines reasonably and in good faith that such disclosure would have a material adverse effect on the Company. 
  

 5 

 4. Further Obligations of the Company. Whenever the Company is required hereunder to
register any Registrable Securities, it agrees that it shall also do the following: 
 (a) Pay all expenses of such registrations and
offerings (exclusive of underwriting fees, commissions, discounts and allowances) and the reasonable fees and expenses of not more than one independent counsel for the Holders in connection with any registrations hereunder; 
 (b) Use its reasonable best efforts diligently to prepare and file with the Commission a registration statement and such amendments and supplements to
said registration statement and the prospectus used in connection therewith as may be necessary to keep said registration statement effective until the Holder or Holders have completed the distribution described in the registration statement
relating thereto (but for no more than 180 days or such lesser period in which all Registrable Securities registered pursuant thereto are sold) and to comply with the provisions of the Securities Act with respect to the sale of securities covered by
said registration statement for such period; 
 (c) Furnish to each selling Holder such copies of each preliminary and final prospectus and
such other documents as such Holder may reasonably request to facilitate the public offering of its Registrable Securities; 
 (d) Enter into
any reasonable underwriting agreement required by the proposed underwriter, if any, in such form and containing such terms as are customary; provided, however, that no Holder shall be required to make any representations or warranties other than
with respect to its title to the Registrable Securities and with respect to any written information provided by the Holder to the Company, and if the underwriter requires that representations or warranties be made and that indemnification be
provided, the Company shall make all such representations and warranties and provide all such indemnities, including, without limitation, in respect of the Company’s business, operations and financial information and the disclosures relating
thereto in the prospectus; 
 (e) Use its reasonable best efforts to register or qualify the securities covered by said registration
statement under the securities or “blue sky” laws of such jurisdictions as any selling Holder may reasonably request; provided, that the Company shall not be required to register or qualify the securities in any jurisdictions in
which such registration or qualification would require it to qualify to do business therein; 
 (f) Immediately notify each selling Holder,
at any time when a prospectus relating to his, her or its Registrable Securities is required to be delivered under the Securities Act, of the happening of any event as a result of which such prospectus contains an untrue statement of a material fact
or omits any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and, at the request of any such selling Holder, prepare a supplement or amendment to such prospectus so
that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading, in
light of the circumstances then existing; 
  

 6 

 (g) Cause all such Registrable Securities to be listed on each securities exchange or quotation system on
which similar securities issued by the Company are then listed or quoted; 
 (h) Otherwise use its reasonable best efforts to comply with the
securities laws of the United States and other applicable jurisdictions and all applicable rules and regulations of the Commission and comparable governmental agencies in other applicable jurisdictions and make generally available to its holders, in
each case as soon as practicable, but not later than forty-five (45) days after the close of the period covered thereby, an earnings statement of the Company which will satisfy the provisions of Section 11(a) of the Securities Act;

 (i) If the offering is underwritten, obtain and furnish to each selling Holder, immediately prior to the effectiveness of the registration
statement and, at the time of delivery of any Registrable Securities sold pursuant thereto, (i) a legal opinion from the Company’s outside counsel, and (ii) a cold comfort letter from the Company’s independent public accountants,
in each case in customary form and covering such matters of the type customarily covered by such opinions or cold comfort letters as the Holders of a majority of the Registrable Securities being sold may reasonably request; and 
 (j) Otherwise cooperate with the underwriter or underwriters, the Commission and other regulatory agencies and take all actions and execute and deliver
or cause to be executed and delivered all documents necessary to effect the registration of any Registrable Securities hereunder. 
 5.
Indemnification; Contribution. 
 (a) Incident to any registration of any Registrable Securities under the Securities Act pursuant
to this Agreement, the Company will indemnify and hold harmless each underwriter and each Holder who offers or sells any such Registrable Securities in connection with such registration statement (including such Holder’s partners (including
partners of partners and stockholders of any such partners), and directors, officers, employees, representatives and agents of any of them (a “Selling Holder”), and each person who controls any of them within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act (a “Controlling Person”)) from and against any and all losses, claims, damages, expenses and liabilities, joint or several (including any investigation,
legal and other expenses incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, as the same are incurred), to which they, or any of them, may become subject under the Securities Act,
the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities arise out of or are based on (i) any untrue statement or alleged untrue statement of a
material fact contained in such registration statement (including any related preliminary or definitive prospectus, or any amendment or supplement to such registration statement or prospectus), (ii) any omission or alleged omission to state in
such document a material fact required to be stated in it or necessary to make the statements in it not misleading, or (iii) any violation by the Company of the Securities Act, any state securities or “blue sky” laws or any rule or
regulation thereunder in connection with such registration; provided, however, that the Company will not be liable to the extent that such loss, 

  

 7 

 
claim, damage, expense or liability arises from and is based on an untrue statement or omission or alleged untrue statement or omission made in reliance on
and in conformity with information furnished in writing to the Company by such underwriter, Selling Holder or Controlling Person expressly for use in such registration statement. With respect to such untrue statement or omission or alleged untrue
statement or omission in the information furnished in writing to the Company by such Selling Holder expressly for use in such registration statement, such Selling Holder will indemnify and hold harmless each underwriter, the Company (including its
directors, officers, employees, representatives and agents) and each other Holder (including such Holder’s partners (including partners of partners and stockholders of such partners) and directors, officers, employees, representatives and
agents of any of them, and each person who controls any of them within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act), from and against any and all losses, claims, damages, expenses and liabilities,
joint or several, to which they, or any of them, may become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise to the same extent provided in the immediately preceding
sentence. In no event, however, shall the liability of a Selling Holder for indemnification under this Section 5(a) exceed the net proceeds received by such Selling Holder from its sale of Registrable Securities under such registration
statement. 
 (b) If the indemnification provided for in Section 5(a) above for any reason is held by a court of competent
jurisdiction to be unavailable to an indemnified party in respect of any losses, claims, damages, expenses or liabilities referred to therein, then each indemnifying party under this Section 5, in lieu of indemnifying such indemnified
party thereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, expenses or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received
by the Company, the Selling Holders and the underwriters from the offering of the Registrable Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, the Selling Holders and the underwriters in connection with the statements or omissions which resulted in such losses, claims,
damages, expenses or liabilities, as well as any other relevant equitable considerations; provided, however, that in the event of a registration statement filed in response to a demand under Section 3(a) and in which the
Company does not register any shares of capital stock, the proportion of contribution by the Company, the Selling Holders and the underwriters shall in all cases be governed by clause (ii) above. The relative benefits received by the Company,
the Selling Holders and the underwriters shall be deemed to be in the same respective proportions that the net proceeds from the offering received by the Company and the Selling Holders and the underwriting discount received by the underwriters, in
each case as set forth in the table on the cover page of the applicable prospectus, bear to the aggregate public offering price of the Registrable Securities. The relative fault of the Company, the Selling Holders and the underwriters shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, the Selling Holders or the
underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
 The Company, the Selling Holders, and the underwriters agree that it would not be just and equitable if contribution pursuant to this Section 5(b) were determined by pro rata or per 

  

 8 

 
capita allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding
paragraph. In no event, however, shall a Selling Holder be required to contribute any amount under this Section 5(b) in excess of the net proceeds received by such Selling Holder from its sale of Registrable Securities under such
registration statement. No person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not found guilty of such fraudulent
misrepresentation. 
 (c) The amount paid by an indemnifying party or payable to an indemnified party as a result of the losses, claims,
damages and liabilities referred to in this Section 5 shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or
defending any such action or claim, payable as the same are incurred. The indemnification and contribution provided for in this Section 5 will remain in full force and effect regardless of any investigation made by or on behalf of the
indemnified parties or any officer, director, employee, agent or Controlling Person of the indemnified parties. No indemnifying party, in the defense of any such claim or litigation, shall enter into a consent of entry of any judgment or enter into
a settlement without the consent of the indemnified party, which consent will not be unreasonably withheld. 
 (d) Notwithstanding the
foregoing, to the extent the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with an underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control. 
 6. Rule 144 and Rule 144A Requirements. In the event that the Company becomes subject
to Section 13 or Section 15(d) of the Exchange Act, the Company shall use its reasonable best efforts to take all action as may be required as a condition to the availability of Rule 144 or Rule 144A under the Securities Act (or any
successor or similar exemptive rules hereafter in effect). The Company shall furnish to any Holder, within fifteen (15) days of a written request, a written statement executed by the Company as to the steps it has taken to comply with the
current public information requirement of Rule 144 or Rule 144A or such successor rules. 
 7. Transferability of Registration
Rights. The registration rights set forth in this Agreement are transferable to (i) any Affiliate of a Holder, (ii) any member of the Group of an Investor, (iii) any family member or trust for the benefit of any individual
Holder, and (iv) subject to the terms of the Stockholders Agreement, any permitted transferee who acquires at least five percent (5%) of the Series D Preferred Stock, Series C Preferred Stock or Series B Preferred Stock; provided,
however, that notice of such transfer shall have been given to the Company within 10 days of such transfer. Each subsequent holder of Registrable Securities must consent in writing to be bound by the terms and conditions of this Agreement in
order to acquire the rights granted pursuant to this Agreement. 
 8. Rights Which May Be Granted to Subsequent Investors.
Other than permitted transferees of Registrable Securities under Section 7 hereof, the Company shall not, without the prior written consent of the holders of not less than a majority of the outstanding Registrable Securities, grant any
other registration rights to any third parties upon terms on a parity with, or more favorable than, the registration rights granted to the Holders hereunder. 
  

 9 

 9. Miscellaneous. 
 (a) Amendments Waivers and Consents. 
 (i) For the purposes of this Agreement and all agreements executed pursuant hereto, no course of dealing between or among any of the parties hereto and no delay on the part of any party hereto in exercising any rights
hereunder or thereunder shall operate as a waiver of the rights hereof and thereof. This Agreement may not be amended or modified or any provision hereof waived without the written consent of the Company and the holders of not less than a majority
of the outstanding Registrable Securities; provided that any party may waive any provision hereof intended for its benefit by written consent. 
 (ii) Notwithstanding anything contained herein to the contrary, the holders of a majority of the outstanding shares of Series D Preferred Stock shall have the right to execute any waiver, modification or amendment of
any provision contained herein, or waive any right or benefit hereunder which inures to the benefit of any single holder of Series D Preferred Stock. 
 (b) Governing Law. This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Delaware without regard to the principles thereof relating to conflict of laws.

 (c) Section Headings and Gender. The descriptive headings in this Agreement have been inserted for convenience only and shall not
be deemed to limit or otherwise affect the construction of any provision hereof. The use in this Agreement of the masculine pronoun in reference to a party hereto shall be deemed to include the feminine or neuter, and vice versa, as the context may
require. 
 (d) Counterparts. This Agreement may be executed simultaneously in any number of counterparts, each of which when so
executed and delivered shall be taken to be an original; but such counterparts shall together constitute but one and the same document. 
 (e) Notices and Demands. All notices, claims, certificates, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if personally delivered or if sent by
nationally-recognized overnight courier, by telecopy, or by registered or certified mail, return receipt requested and postage prepaid, addressed as follows: 
 (i) if to the Company, at its address as shown on the signature pages hereto, or at any other address designated by the Company to the
Investors in writing, with a copy to: 
 Fulbright & Jaworski LLP 
 666 Fifth Avenue 
  

 10 

 New York, New York 10103 
 Attention: Paul Jacobs, Esq.; and 
 (ii) if to the Series D Investors, at the mailing addresses as shown on the signature pages hereto, or at such other address designated by a Series D Investor to the Company in writing with a copy to: 
 O’Melveny & Myers LLP 
 Times Square Tower 
 7 Times Square 
 New York, New York 10036 
 Attention: Ilan Nissan, Esq.; and 
 (iii) if to an Investor holding Series B Preferred Stock
or Series C Preferred Stock, at the mailing addresses as shown on the signature pages hereto, or at such other address designated by an Investor holding Series B Preferred Stock or Series C Preferred Stock to the Company in writing with a copy to:

 Goodwin Procter LLP 
 Exchange Place 
 Boston, Massachusetts 02109 
 Attention: David P. Lewis, Esq. 
 or to such
other address as the party to whom notice is to be given may have furnished to the other parties in writing in accordance herewith. Any such notice or communication shall be deemed to have been received (a) in the case of personal delivery, on
the date of such delivery if a business day or, if not a business day, the next succeeding business day, (b) in the case of nationally-recognized overnight courier, on the next business day after the date when sent, (c) in the case of
telecopy transmission, when received if a business day or, if not a business day, the next succeeding business day, and (d) in the case of mailing, on the third business day following that on which the piece of mail containing such
communication is posted. 
 (f) Remedies; Severability. It is specifically understood and agreed that any breach of the
provisions of this Agreement by any person subject hereto will result in irreparable injury to the other parties hereto, that the remedy at law alone will be an inadequate remedy for such breach, and that, in addition to any other remedies which
they may have, such other parties may enforce their respective rights by actions for specific performance (to the extent permitted by law). Whenever possible, each provision of this Agreement shall be interpreted in such a manner as to be effective
and valid under applicable law, but if any provision of this Agreement shall be deemed prohibited or invalid under such applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, and such prohibition or
invalidity shall not invalidate the remainder of such provision or the other provisions of this Agreement. 
 (g) Integration.
This Agreement, including the exhibits, documents and instruments referred to herein or therein, constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, among the parties with respect to
the subject matter hereof, including, without limitation, the Letter of Intent dated April 21, 2004 between the Company and the Insight Venture Management, LLC and the Prior Registration Rights Agreement. 
 [SIGNATURE PAGES FOLLOW] 
  

 11 

 IN WITNESS WHEREOF, the parties hereto have caused this Amended and Restated Registration Rights
Agreement to be duly executed as of the date first set forth above. 
  

			
	COMPANY:
	
	MEDIDATA SOLUTIONS, INC.
		
	By:	 	 /s/ Tarek Sherif

	Name:	 	Tarek Sherif
	Title:	 	President and Chief Executive officer

			
		
	Address:	 	79 Fifth Avenue
		 	New York, New York 10003

			
	INVESTORS:
	
	MILESTONE VENTURE PARTNERS II LP
		
	By:	 	 /s/ Edwin A. Goodman

	Name:	 	Edwin A. Goodman
	Title:	 	Member

			
		
	Address:	 	551 Madison Avenue
		 	7th Floor
		 	New York, NY 10022

			
	
	LAMBDA IV, LLC
		
	By:	 	 /s/ Anthony M. Lamport

	Name:	 	Anthony M. Lamport
	Title:	 	Manager

			
		
	Address:	 	Lambda Fund Management, Inc.
		 	147 East 48th Street
		 	New York, NY 10017

			
	
	GLOBALNET PARTNERS LP
		
	By:	 	 /s/ Jonathan Adler

	Name:	 	Jonathan Adler
	Title:	 	Managing Director

			
		
	Address:	 	521 Fifth Avenue
		 	Suite 1703
		 	New York, NY 10175

			
	STONEHENGE CAPITAL FUND NEW YORK, LLC
		
	By:	 	 /s/ W. Stephen Keller

	Name:	 	W. Stephen Keller
	Title:	 	Vice President

			
		
	Address:	 	152 West 57th Street
		 	20th Floor
		 	New York, NY 10019-3310

  

			
	INSIGHT VENTURE PARTNERS IV, L.P.
		
	By:	 	 Insight Venture Associates IV, L.L.C.
 its General
Partner

		
	By:	 	 /s/ Peter Sobiloff

	Name:	 	Peter Sobiloff
	Title:	 	Managing Director
	
	INSIGHT VENTURE PARTNERS (CAYMAN) IV, L.P.
		
	By:	 	 Insight Venture Associates IV, L.L.C.
 its Investment
General Partner

		
	By:	 	 /s/ Peter Sobiloff

	Name:	 	Peter Sobiloff
	Title:	 	Managing Director
	
	INSIGHT VENTURE PARTNERS IV (CO-INVESTORS), L.P.
		
	By:	 	 Insight Venture Associates IV, L.L.C.,
 its General
Partner

		
	By:	 	 /s/ Peter Sobiloff

	Name:	 	Peter Sobiloff
	Title:	 	Managing Director
	
	INSIGHT VENTURE PARTNERS IV (FUND B), L.P.
		
	By:	 	 Insight Venture Associates IV, L.L.C.,
 its General
Partner

		
	By:	 	 /s/ Peter Sobiloff

	Name:	 	Peter Sobiloff
	Title:	 	Managing Director

  

			
	SILICON ALLEY VENTURES, LP
		
	By:	 	 /s/ Stephen B. Brotman

	Name:	 	Stephen B. Brotman
	Title:	 	General Partner

			
		
	Address:	 	152 West 57th Street
		 	20th Floor
		 	New York, NY 10019-3310

 EXHIBIT I 
 FORM OF JOINDER AGREEMENT 
 The undersigned hereby agrees, effective as of the date hereof, to become
a party to that certain Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”) dated as of May 27, 2004 by and among Medidata Solutions, Inc. (the “Company”) and the other
parties named therein, and for all purposes of the Agreement, the undersigned shall be included within the term “Investor” (as defined in the Agreement). The address and facsimile number to which notices may be sent to the undersigned is
as follows: 
  

			
	  

	Facsimile No.	 	  

		 	

			
	  

	[NAME OF UNDERSIGNED]Agreement and Plan of Merger

 Exhibit 10.10 
 EXECUTION COPY 
 AGREEMENT AND PLAN OF MERGER 
 dated as of February 13, 2008 
 among 
 MEDIDATA SOLUTIONS, INC. 
 FT
ACQUISITION CORP. 
 FAST TRACK SYSTEMS, INC. 
 and 
 SHAREHOLDER REPRESENTATIVE SERVICES LLC 

 TABLE OF CONTENTS 
  

							
	 	  	 	 	 	  	PAGE
	 ARTICLE I
	  	DEFINITIONS	  	1
			
	           Section 1.01
	 	Certain Defined Terms	  	1
			
	           Section 1.02
	 	Terms Generally	  	10
			
	 ARTICLE II
	  	 THE MERGER
	  	10
			
	           Section 2.01
	 	The Merger	  	10
			
	           Section 2.02
	 	Effective Time	  	10
			
	           Section 2.03
	 	Effect of the Merger	  	11
			
	           Section 2.04
	 	Articles of Incorporation and By-laws	  	11
			
	           Section 2.05
	 	Directors and Officers	  	11
			
	           Section 2.06
	 	Effect of Merger on the Capital Stock of the Constituent Corporations	  	11
			
	           Section 2.07
	 	Dissenting Shares	  	13
			
	           Section 2.08
	 	Exchange of Certificates	  	13
			
	           Section 2.09
	 	Shareholder Representative	  	15
			
	           Section 2.10
	 	Securities Act Exemption	  	16
			
	 ARTICLE III
	  	REPRESENTATIONS AND WARRANTIES OF THE COMPANY	  	16
			
	           Section 3.01
	 	Organization, Etc	  	17
			
	           Section 3.02
	 	Capitalization	  	17
			
	           Section 3.03
	 	Authorization	  	18
			
	           Section 3.04
	 	No Violation	  	18
			
	           Section 3.05
	 	Approvals	  	19
			
	           Section 3.06
	 	Financial Statements and Other Information	  	19
			
	           Section 3.07
	 	Absence of Certain Changes or Events	  	20
			
	           Section 3.08
	 	Taxes	  	21
			
	           Section 3.09
	 	Litigation	  	23
			
	           Section 3.10
	 	Compliance with Laws	  	24
			
	           Section 3.11
	 	Property	  	24
			
	           Section 3.12
	 	Environmental Matters	  	24
			
	           Section 3.13
	 	Condition of the Assets and Related Matters	  	25
			
	           Section 3.14
	 	Employee Plans and Labor Matters	  	25

  

 -i- 

 TABLE OF CONTENTS 
 (CONTINUED) 
  

							
	 	  	 	 	 	  	PAGE
	           Section 3.15
	 	Contracts	  	27
			
	           Section 3.16
	 	Insurance Policies	  	28
			
	           Section 3.17
	 	Records	  	28
			
	           Section 3.18
	 	Brokers	  	28
			
	           Section 3.19
	 	Suppliers and Customers	  	29
			
	           Section 3.20
	 	Intellectual Property	  	29
			
	           Section 3.21
	 	Licenses	  	33
			
	           Section 3.22
	 	No Illegal or Improper Transactions	  	33
			
	 ARTICLE IV
	  	REPRESENTATIONS AND WARRANTIES OF THE PURCHASER AND MERGER
SUB	  	33
			
	           Section 4.01
	 	Purchaser Organization, Etc	  	33
			
	           Section 4.02
	 	Capitalization	  	34
			
	           Section 4.03
	 	Authorization	  	34
			
	           Section 4.04
	 	No Violation	  	35
			
	           Section 4.05
	 	Approvals	  	35
			
	           Section 4.06
	 	Financial Statements and Other Information	  	35
			
	           Section 4.07
	 	Absence of Certain Changes or Events	  	36
			
	           Section 4.08
	 	Litigation	  	36
			
	           Section 4.09
	 	Issuance	  	36
			
	           Section 4.10
	 	Taxes	  	36
			
	           Section 4.11
	 	Intellectual Property	  	36
			
	 ARTICLE V
	  	COVENANTS	  	37
			
	           Section 5.01
	 	General	  	37
			
	           Section 5.02
	 	Access to Premises and Information	  	38
			
	           Section 5.03
	 	Conduct of Business in Ordinary Course	  	38
			
	           Section 5.04
	 	Updating of Disclosure Schedules	  	39
			
	           Section 5.05
	 	Further Assurances	  	39
			
	           Section 5.06
	 	No Shopping	  	39
			
	           Section 5.07
	 	Consents	  	40
			
	           Section 5.08
	 	Public Announcements	  	41

  

 -ii- 

 TABLE OF CONTENTS 
 (CONTINUED) 
  

							
	 	  	 	 	 	  	PAGE
	           Section 5.09
	 	Confidentiality Obligations of the Parties	  	41
			
	           Section 5.10
	 	Updated Financial Statements	  	41
			
	           Section 5.11
	 	Employee Matters	  	41
			
	           Section 5.12
	 	Certain Tax Matters	  	42
			
	           Section 5.13
	 	Financial Statement Audit	  	43
			
	 ARTICLE VI
	  	ADDITIONAL AGREEMENTS	  	43
			
	           Section 6.01
	 	Proxy Statement and Shareholder Meeting	  	43
			
	           Section 6.02
	 	Shareholder Meeting	  	44
			
	           Section 6.03
	 	Blue Sky Laws	  	44
			
	 ARTICLE VII
	  	CONDITIONS PRECEDENT TO OBLIGATIONS OF THE PURCHASER	  	44
			
	           Section 7.01
	 	Accuracy of Representations and Warranties	  	44
			
	           Section 7.02
	 	Performance	  	45
			
	           Section 7.03
	 	No Material Adverse Effect	  	45
			
	           Section 7.04
	 	Certificates	  	45
			
	           Section 7.05
	 	Absence of Litigation	  	45
			
	           Section 7.06
	 	Legal Prohibition	  	45
			
	           Section 7.07
	 	Consents, Approvals, Licenses, etc	  	45
			
	           Section 7.08
	 	Employment Arrangements	  	46
			
	           Section 7.09
	 	Escrow Agreement	  	46
			
	           Section 7.10
	 	Closing Matters	  	46
			
	           Section 7.11
	 	Securities Act Exemption	  	46
			
	           Section 7.12
	 	Opinion	  	46
			
	           Section 7.13
	 	FIRPTA	  	46
			
	           Section 7.14
	 	Shareholder Approval	  	46
			
	           Section 7.15
	 	Resignations	  	46
			
	           Section 7.16
	 	Shareholder Agreement	  	46
			
	           Section 7.17
	 	Registration Rights Agreement	  	46
			
	           Section 7.18
	 	Dissenting Shares	  	47
			
	           Section 7.19
	 	Financial Condition	  	47

  

 -iii- 

 TABLE OF CONTENTS 
 (CONTINUED) 
  

							
	 	  	 	 	 	  	PAGE
	           Section 7.20
	 	Warrants	  	47
			
	           Section 7.21
	 	Existing Shareholder Agreements	  	47
			
	 ARTICLE VIII
	  	CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY	  	47
			
	           Section 8.01
	 	Accuracy of Representations and Warranties	  	47
			
	           Section 8.02
	 	Performance	  	48
			
	           Section 8.03
	 	No Material Adverse Effect	  	48
			
	           Section 8.04
	 	Certification by the Purchaser	  	48
			
	           Section 8.05
	 	Absence of Litigation	  	48
			
	           Section 8.06
	 	Legal Prohibition	  	48
			
	           Section 8.07
	 	Shareholder Approval	  	48
			
	           Section 8.08
	 	Ancillary Agreements	  	48
			
	           Section 8.09
	 	Closing Matters	  	48
			
	 ARTICLE IX
	  	INDEMNIFICATION	  	49
			
	           Section 9.01
	 	Indemnification by the Purchaser	  	49
			
	           Section 9.02
	 	Indemnification by the Company	  	50
			
	           Section 9.03
	 	Notification of Claims	  	51
			
	           Section 9.04
	 	Survival of Representations and Warranties	  	52
			
	           Section 9.05
	 	Other Indemnification Provisions	  	53
			
	           Section 9.06
	 	Tax Treatment of Indemnification Payments	  	53
			
	 ARTICLE X
	  	TERMINATION	  	53
			
	           Section 10.01
	 	Termination of Agreement	  	53
			
	           Section 10.02
	 	Effect of Termination	  	54
			
	 ARTICLE XI
	  	GENERAL PROVISIONS	  	54
			
	           Section 11.01
	 	Effect of Due Diligence	  	54
			
	           Section 11.02
	 	Expenses	  	54
			
	           Section 11.03
	 	Notices	  	55
			
	           Section 11.04
	 	Headings	  	56
			
	           Section 11.05
	 	Severability	  	56
			
	           Section 11.06
	 	Entire Agreement	  	56
			
	           Section 11.07
	 	Assignment	  	56

  

 -iv- 

 TABLE OF CONTENTS 
 (CONTINUED) 

							
	 	  	PAGE
	           Section 11.08
	 	No Third-Party Beneficiaries	  	56
			
	           Section 11.09
	 	Amendment, Waiver	  	56
			
	           Section 11.10
	 	Governing Law; Submission to Jurisdiction, Waivers	  	56
			
	           Section 11.11
	 	Counterparts	  	57
			
	           Section 11.12
	 	Construction	  	57
			
	           Section 11.13
	 	Specific Performance	  	57

 EXHIBITS 
  

			
	Exhibit A	 	Form of Voting Agreement
	Exhibit B	 	Form of Amendment
	Exhibit 2.02	 	Form of Agreement of Merger and Officer’s Certificate
	Exhibit 2.04(a)	 	Form of Amended and Restated Articles of Incorporation
	Exhibit 2.04(b)	 	Form of Amended and Restated By-laws
	Exhibit 7.07	 	Required Consents
	Exhibit 7.08	 	Certain Employees
	Exhibit 7.09	 	Form of Escrow Agreement
	Exhibit 7.12	 	Form of Opinion of Counsel to the Company
	Exhibit 7.16	 	Form of Shareholder Agreement
	Exhibit 7.17	 	Form of Registration Rights Agreement
	Exhibit 7.20	 	Company Warrants
	Exhibit 8.10	 	Letter Agreement

  

 -v- 

 AGREEMENT AND PLAN OF
MERGER, dated as of February 13, 2008, among MEDIDATA SOLUTIONS, INC., a Delaware corporation (the “Purchaser”), FT
ACQUISITION CORP., a California corporation and wholly-owned subsidiary of Purchaser (the “Merger Sub”), FAST TRACK SYSTEMS,
INC., a California corporation (the “Company”), and SHAREHOLDER REPRESENTATIVE SERVICES LLC, a Colorado limited liability company, in its capacity as
shareholder representative (the “Shareholder Representative”). 
 RECITALS 
 A. The boards of directors of each of Purchaser, Merger Sub and the Company believe it is in the best interests of each corporation and its
respective stockholders that Purchaser acquire the Company through the statutory merger of Merger Sub with and into the Company (the “Merger”) and, in furtherance thereof, have approved the Merger. 
 B. Pursuant to the Merger and this Agreement, each of the issued and outstanding shares of capital stock of the Company shall be converted into
the right to receive the consideration set forth herein. 
 C. The Company, on the one hand, and Purchaser and Merger Sub, on the
other hand, desire to make certain representations, warranties, covenants and other agreements in connection with the Merger. 
 D. To
induce Purchaser and Merger Sub to enter into this Agreement, on the date hereof certain holders of capital stock of the Company are entering into a voting agreement with Purchaser (the “Voting Agreement”) in the form of the
attached Exhibit A, pursuant to which they have agreed to vote in favor of the Merger and not solicit transactions that would compete with or be an alternative to the Merger. 
 E. For federal income Tax purposes, it is intended by Purchaser and the Company that the Merger shall qualify as a “reorganization”
within the meaning of Section 368(a) of the Code, and that this Agreement shall constitute a plan of “reorganization.” 
 NOW, THEREFORE, in consideration of the mutual agreements, covenants and other promises set forth herein, the mutual benefits to be gained by the performance thereof, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, the parties hereby agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 Section 1.01 Certain Defined Terms. In addition to the terms defined elsewhere in this Agreement, as used herein, the following terms shall have the meanings indicated below. 
 “Action” means any claim, action, suit, arbitration, inquiry, proceeding or investigation by or before any Governmental Authority
or arbitration panel. 
  

 1. 

 “Affiliate” means, with respect to any specified Person, any other Person that,
directly or indirectly through one or more intermediaries, Controls, is Controlled by or is under common Control with such specified Person. 
 “Agreement” means this Agreement, including the Company Disclosure Schedule, the Purchaser Disclosure Schedule, the other Schedules and the Exhibits and all amendments hereto. 
 “Amendment” means the amendment to the Restated Articles substantially in the form attached as Exhibit B hereto.

 “Ancillary Agreements” means the Shareholder Agreement, the Registration Rights Agreement, the Voting Agreement
and the Escrow Agreement. 
 “Assets” means any assets, whether tangible or intangible, of the Company. 

“Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to
be closed in the City of New York. 
 “CGCL” means the California General Corporation Law. 
 “Code” means the Internal Revenue Code of 1986, as amended. 
 “Company Capital Stock” means Company Common Stock and Company Preferred Stock. 
 “Company Common Stock” means the common stock, par value $0.001, of the Company. 
 “Company Disclosure Schedule” means the disclosure schedule delivered by the Company to the Purchaser on the date hereof.

 “Company Intellectual Property” means (a) the Registered Intellectual Property; (b) Company Software;
and (c) trade secrets that the Company elects to keep confidential. 
 “Company Material Adverse Effect” means
any change, effect, event, occurrence, state of facts or development that is materially adverse to the business, financial condition or results of operations of the Company or to the Company’s ability to perform its obligations under this
Agreement; provided, however, that none of the following shall be deemed in themselves, either alone or in combination, to constitute, and none of the following shall be taken into account in determining whether there has been or will be, a
Company Material Adverse Effect: (a) any failure by the Company to meet internal projections or forecasts for any period ending on or after the date of this Agreement, provided, however, that this clause (a) shall not preclude any
underlying change, effect, event, occurrence, state of facts or development which may have caused such failure to meet internal projections or forecasts from being treated as a Company Material Adverse Effect; (b) any adverse change, effect,
event, occurrence, state of facts or development to the extent attributable to the announcement or pendency of the Merger (including any cancellations of or delays in customer orders, any reduction in sales, any 

  

 2. 

 
disruption in supplier, distributor, partner or similar relationships or any loss of employees); (c) any adverse change, effect, event, occurrence,
state of facts or development attributable to conditions affecting the industries in which the Company participates, the U.S. economy as a whole or foreign economies in any locations where the Company has material operations or sales, provided
that the Company is not materially disproportionately affected compared to other companies; (d) the incurrence by the Company of Transaction Expenses, provided that on the Closing Date the Company has cash in excess of its aggregate
Transaction Expenses that have not been paid; (e) the payment of amounts due to, or the provision of other benefits (including benefits relating to acceleration of stock options) to, any officers or employees, provided such amounts or benefits
do not exceed those set forth on Section 3.14(f) of the Company Disclosure Schedule or required by Law; or (f) any adverse change, effect, event, occurrence, state of facts or development arising from or relating to any change in GAAP or
any change in applicable laws, rules or regulations or the interpretation thereof.\ 
 “Company Option” means any
option to purchase any shares of Company Capital Stock. 
 “Company Preferred Stock” means the Series 1 Preferred and
the Series 2 Preferred. 
 “Company Software” means all computer software, databases and data collections and all
rights thereto, including all enhancements, versions, releases and updates of such computer software, developed by or for the Company, and any other computer software, regardless of the computer software’s stage of development, in each case
that is owned by the Company. “Company Software” includes all source code, object code, firmware, development tools, files, records and data, and all media on which any of the foregoing is recorded. “Company
Software” does not include computer software that is licensed (a) from third parties or (b) under the licenses of Intellectual Property owned by third parties that constitutes (i) “shrink wrap” software or
(ii) third party software generally available to the public at a cost of less than $10,000. 
 “Company Warrant”
means any warrant to purchase any shares of Company Capital Stock. 
 “Continuing Employees” means the Company
Employees who continue employment with the Purchaser. 
 “Contract” means any oral or written agreement, letter of
understanding, lease, license or sublicense, evidence of Debt, mortgage, indenture, security agreement, deed of trust or other contract, commitment, arrangement, understanding or obligation. 
 “Control” means, as to any Person, the power to direct or cause the direction of the management and policies of such Person,
whether through the ownership of voting securities, by Contract or otherwise. The term “Controlled” shall have a correlative meaning. 
 “Debt” means (a) any indebtedness for borrowed money, whether short term or long term, (b) any indebtedness arising under capital leases, (c) all obligations evidenced by notes, bonds, debentures or
other similar instruments, (d) all liabilities under any foreign 

  

 3. 

 
exchange agreement, interest rate protection or swap agreement or similar agreement designed to protect against fluctuations in interest rates, (e) all
interest, fees and other expenses owed with respect to indebtedness referred to in clauses (a) through (d) above, and (f) all indebtedness of others referred to in clauses (a) through (e) above that is guaranteed.

 “Director Option” means any Company Option held by Alph Bingham, John Kingery, Scott Minick or
Barry Weinberg. 
 “Employee Option” means any Company Option held by Peter Abramowitsch, Anita Andreasen,
Christopher Bean, Charles Beitz III, Theresa Brophy, Rafael Campo, Adrienne Card, Frank Cattie, Mary Cherry, Mary Ann Danishefsky, Jessica Dolfi, David Gemzik, Joshua Hartman, Craig Hotter, Melvin Laguren, Elizabeth Loscalzo, Margarita Mateo, Lynda
Maxwell, Michael Meyer, Nadine Parmelee, Sandra Pepe, Matt Riley, Phil Servedio, Lori Shields, Charles Swanson or Tonya Tang. 
 “Environmental Law” means any Law relating to: (a) the protection, investigation or restoration of the environment, health, safety, or natural resources, (b) the handling, use, presence, disposal, release
or threatened release of any Hazardous Substance or (c) noise, odor, indoor air, employee exposure, wetlands, pollution, contamination or any injury or threat of injury to persons or property relating to any Hazardous Substance. 
 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 
 “Escrow Agent” means a bank or trust company mutually agreed on by the Purchaser and the Company. 
 “Escrow Agreement” means the Escrow Agreement, substantially in the form attached hereto as Exhibit 7.09, to be entered
into pursuant to Section 7.09. 
 “Exchange Ratio” means the quotient obtained by dividing (a) the
Remaining Merger Consideration by (b) the Fully Diluted Company Shares. 
 “Fully Diluted Company Shares” will
be equal to the sum, without duplication, of (a) the aggregate number of shares of Company Common Stock that are issued and outstanding immediately prior to the Effective Time, (b) the aggregate number of shares of Company Common Stock
that are issuable upon the conversion of shares of Company Preferred Stock that are issued and outstanding immediately prior to the Effective Time, excluding accrued but unpaid dividends on such shares of Company Preferred Stock, (c) the
aggregate number of shares of Company Common Stock that are issuable upon the exercise of options, warrants or other direct or indirect rights to acquire shares of Company Common Stock that are issued and outstanding immediately prior to the
Effective Time (whether or not then vested or exercisable), and (d) the aggregate number of shares of Company Common Stock that are issuable upon the conversion of shares of Company Preferred Stock that are issuable upon the exercise of
options, warrants or other direct or indirect rights to acquire shares of Company Preferred Stock that are issued and outstanding immediately prior to the Effective Time (whether or not then vested or exercisable). 
  

 4. 

 “Fully Diluted Purchaser Shares” will be equal to the sum, without duplication,
of (a) the aggregate number of shares of Purchaser Common Stock that are issued and outstanding immediately prior to the Effective Time, (b) the aggregate number of shares of Purchaser Common Stock that are issuable upon the conversion of
shares of Purchaser Preferred Stock that are issued and outstanding immediately prior to the Effective Time, including accrued but unpaid dividends on such shares of Purchaser Preferred Stock, (c) the aggregate number of shares of Purchaser
Common Stock that are issuable upon the exercise of options, warrants or other direct or indirect rights to acquire shares of Purchaser Common Stock that are issued and outstanding immediately prior to the Effective Time (whether or not then vested
or exercisable), (d) the aggregate number of shares of Purchaser Common Stock that are issuable upon the conversion of shares of Purchaser Preferred Stock that are issuable upon the exercise of options, warrants or other direct or indirect
rights to acquire shares of Purchaser Preferred Stock that are issued and outstanding immediately prior to the Effective Time (whether or not then vested or exercisable) and (e) the aggregate number of shares of Purchaser Common Stock that are
available for issuance pursuant to any equity incentive plan of Purchaser as of immediately prior to the Effective Time. 
 “GAAP” means United States generally accepted accounting principles. 
 “Governmental
Authority” means any United States federal, state or local or any foreign government, governmental, regulatory, taxing or administrative authority, agency or commission or court, tribunal or judicial or arbitral body or any private
arbitrator. 
 “Governmental Order” means any order, writ, judgment, injunction, decree, stipulation, determination
or award entered by or with any Governmental Authority. 
 “Hazardous Substance” means any substance that is:
(a) listed, classified or regulated pursuant to any Environmental Law; (b) any petroleum product or by-product, asbestos-containing material, lead-containing paint or plumbing, polychlorinated biphenyls, radioactive material, mold or
radon; and (c) any other substance which may be the subject of regulatory action by any Governmental Authority in connection with any Environmental Law. 
 “Intellectual Property” means any or all of the following and all rights in, arising out of, or associated therewith, whether registered or unregistered, as applicable: (a) United States
and non-United States patents and applications therefor and all reissues, divisions, renewals, extensions, provisionals, continuations and continuations-in-part thereof; (b) inventions and discoveries (whether or not patentable and whether
disclosed or undisclosed), disclosures on inventions, trade secrets, proprietary information, know-how, technical data and customer lists, and all documentation relating to any of the foregoing; (c) copyrights, copyright registrations and
applications therefor and all other corresponding rights thereto throughout the world; (d) industrial designs and any registrations and applications therefor throughout the world; (e) trade names, logos, trademarks and service marks, and
trademark and service mark registrations and applications therefor and all goodwill associated with the foregoing throughout the world; and (f) databases and data collections and all rights therein throughout the world to the extent in which a
legally recognized intellectual property right exists. 
  

 5. 

 “Knowledge”, “to the Knowledge of” or phrases of similar
import shall mean, with respect to any party hereto, actual knowledge of the directors and executive officers of such party (or persons holding comparable positions). 
 “Law” means any federal, state, local or foreign statute, law, ordinance, regulation, rule, code, order or other requirement or rule of law. 
 “Licenses” means all licenses, permits, certificates of authority, authorizations, approvals, registrations, filings,
qualifications, privileges, franchises and similar consents granted or issued by any Governmental Authority. 
 “Lien” means any mortgage, deed of trust, pledge, hypothecation, security interest, encumbrance, claim, lien or charge of any kind, or any conditional sales Contract, title retention Contract or other Contract to
create any of the foregoing (it being understood that a Contract which permits a purchaser to return items purchased thereunder shall not be deemed to constitute a Lien solely by virtue thereof and a Contract granting or permitting a non-exclusive
license of any Company Intellectual Property shall not be deemed to constitute a Lien solely by virtue thereof). 
 “Merger
Consideration” means such number of shares of Purchaser Common Stock as, when added to the Fully Diluted Purchaser Shares, will equal 4.762% of the sum. 
 “Permitted Liens” means the following Liens: (a) Liens for Taxes, assessments or other governmental charges or levies that are not yet due or payable, (b) statutory Liens of landlords
and Liens of carriers, warehousemen, mechanics, materialmen and repairmen and other Liens imposed by Law for amounts not yet due, (c) Liens incurred or deposits made in the ordinary course of business of the Company consistent with past
practice in connection with worker’s compensation, unemployment insurance or other types of social security, and (d) Liens not created by the Company which affect the underlying fee interest of any Leased Real Property (as defined herein).

 “Person” means any natural person, general or limited partnership, trust, corporation, limited liability company,
firm, association, Governmental Authority or other legal entity. 
 “Pre-Closing Partial Period” means the portion of
any Straddle Period up to and including the Closing Date. 
 “Pre-Closing Period” means a taxable period ending on or
prior to the Closing Date. 
 “Preferred Stock Liquidation Amount” means, with respect to each share of Company
Preferred Stock, the sum of (a) an amount equal to the Series 1 Original Purchase Price (as defined in the Restated Articles) or Series 2 Original Purchase Price (as defined in the Restated Articles), as applicable, of such share, as adjusted
in accordance with the Restated Articles for stock splits, stock dividends or recapitalizations, plus (b) an amount equal to any dividends accrued but unpaid on such share calculated in accordance with the Restated Articles. 
  

 6. 

 “Preferred Stock Liquidation Shares” has the meaning set forth in
Section 2.06(a)(i). 
 “Purchaser Capital Stock” mean Purchaser Common Stock and Purchaser Preferred Stock.

 “Purchaser Common Stock” means the common stock, par value $0.01, of Purchaser. 
 “Purchaser Disclosure Schedule” means the disclosure schedule delivered by the Purchaser to the Company on the date hereof.

 “Purchaser Material Adverse Effect” means any change, effect, event, occurrence, state of facts or development
that is materially adverse to the business, financial condition or results of operations of the Purchaser and its Subsidiaries taken as a whole or to the Purchaser’s or Merger Sub’s ability to perform its obligations under this Agreement;
provided, however, that none of the following shall be deemed in themselves, either alone or in combination, to constitute, and none of the following shall be taken into account in determining whether there has been or will be, a Purchaser
Material Adverse Effect: (a) any failure by the Purchaser to meet internal projections or forecasts for any period ending on or after the date of this Agreement, provided, however, that this clause (a) shall not preclude any
underlying change, effect, event, occurrence, state of facts or development which may have caused such failure to meet internal projections or forecasts from being treated as a Purchaser Material Adverse Effect; (b) any adverse change, effect,
event, occurrence, state of facts or development to the extent attributable to the announcement or pendency of the Merger (including any cancellations of or delays in customer orders, any reduction in sales, any disruption in supplier, distributor,
partner or similar relationships or any loss of employees); (c) any adverse change, effect, event, occurrence, state of facts or development attributable to conditions affecting the industries in which the Purchaser participates, the U.S.
economy as a whole or foreign economies in any locations where the Purchaser has material operations or sales, provided that the Purchaser and its Subsidiaries taken as a whole are not materially disproportionately affected compared to other
companies; or (d) any adverse change, effect, event, occurrence, state of facts or development arising from or relating to any change in GAAP or any change in applicable laws, rules or regulations or the interpretation thereof. 
 “Purchaser Preferred Stock” means any and all classes of preferred stock, par value $0.01, of the Purchaser, including the
Purchaser’s Series A Convertible Preferred Stock, the Purchaser’s Series B Convertible Redeemable Preferred Stock, the Purchaser’s Series C Convertible Redeemable Preferred Stock, and the Purchaser’s Series D Convertible
Redeemable Preferred Stock. 
 “Purchaser Stock Price” means the fair market value of one share of Purchaser Common
Stock as reasonably determined in good faith by the board of directors of Purchaser on the date that the Losses in question are satisfied pursuant to Article IX hereof or any payments are made from the Escrow Fund pursuant to Section 2.09
hereof (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like after the date hereof). In the event that the Purchaser is acquired or engages in a similar transaction or series of transactions after the 

  

 7. 

 
date of this Agreement resulting in no Purchaser Common Stock being outstanding on the date that any Losses are satisfied pursuant to Article IX hereof, the
Purchaser Stock Price shall mean the current value of the consideration received for one share of Purchaser Common Stock in connection with such acquisition or similar transaction or series of transactions. 
 “Registered Intellectual Property” means all of the following items of Intellectual Property owned by the Company:
(a) United States and non-United States issued patents and patent applications (including provisional applications); (b) registered trademarks, applications to register trademarks, intent to use applications or other registrations related
to trade identity and trademarks; (c) registered copyrights and applications for copyright registration; (d) mask work registrations and applications to register mask works; (e) all registrations for domain names; and (f) any
other Intellectual Property that is the subject of an application, certificate or registration filed with, issued by, or recorded by, any Governmental Authority. 
 “Release” means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping or disposing into the environment. 
 “Remaining Merger Consideration” means the Merger Consideration, minus the Preferred Stock Liquidation Shares. 
 “Restated Articles” means the Company’s Seventh Amended and Restated Articles of Incorporation, as they may be amended in
accordance with the terms of this Agreement. 
 “Series 1 Preferred” means the Series 1 Preferred Stock, par value
$.001, of the Company. 
 “Series 2 Preferred” means the Series 2 Preferred Stock, par value $.001, of the Company.

 “Shareholder Approval” shall mean (A) the approval and adoption of this Agreement, the Ancillary Agreements,
the Merger and the transactions contemplated hereby and thereby by (i) a majority of the outstanding shares of Company Common Stock, voting separately as a class, and (ii) a majority of the outstanding shares of Company Preferred Stock,
voting separately as a class and (B) the approval of the Amendment by (i) the holders of a number of shares of Series 1 Preferred greater than one hundred six percent (106%) of the number of shares held of record by the largest holder
of Series 1 Preferred (provided however, that if such number is greater than the number of shares of Series 1 Preferred then outstanding, then the unanimous approval of the holders of then outstanding Series 1 Preferred shall be required and
if such number is less than a majority of the Series 1 Preferred then outstanding, then the approval of the holders of a majority of the Series 1 Preferred then outstanding shall be required), and (ii) the holders of a number of shares of
Series 2 Preferred greater than one hundred six percent (106%) of the number of shares held of record by the largest holder of Series 2 Preferred (provided however, that if such number is greater than the number of shares of Series 2
Preferred then outstanding, then the unanimous approval of the holders of then outstanding Series 2 Preferred shall be required and if such number is less than a majority of the Series 2 Preferred then outstanding, then the approval of the holders
of a majority of the Series 2 Preferred then outstanding shall be required). 
  

 8. 

 “Straddle Period” means a taxable period beginning before the Closing Date and
ending after the Closing Date. 
 “Subsidiary” of any Person means any corporation, partnership, joint venture,
limited liability company, trust, estate or other Person of which (or in which) more than 50% of (a) the issued and outstanding capital stock or other equity interests having ordinary voting power to elect a majority of the board of directors
of such corporation or Persons performing similar functions of any other Person (irrespective of whether at the time capital stock or other equity interests of any other class or classes of such corporation or other Person shall or might have voting
power upon the occurrence of any contingency), (b) the interest in the capital or profits of such partnership, joint venture or limited liability company or other Person, or (c) the beneficial interest in such trust or estate is at the
time directly or indirectly owned or controlled by such Person, by such Person and one or more of its other Subsidiaries or by one or more of such Person’s other Subsidiaries. 
 “Tax” or “Taxes” means (a) any tax (including any income, franchise, capital gains, employment,
value-added, sales, use, real property, personal property, business license, gift, estate, gross receipts, capital, import, goods and services, estimated, alternative minimum, add-on minimum, transfer, registration, excise, natural resources,
severance, stamp, occupation, premium, windfall profit, environmental (including taxes under Section 59A of the Code), capital stock, social security (or similar), unemployment, disability, payroll, license, employee withholding, unclaimed
property, escheat or other tax), levy, assessment, tariff, duty (including any customs duty), deficiency, or other fee of any kind whatsoever (whether payable directly or by withholding), whether disputed or not, and any related unit or amount
(including any fine, penalty, interest, or addition to tax), imposed, assessed, or collected by or under the authority of any Governmental Authority or payable pursuant to any tax sharing agreement or any other Contract relating to the sharing or
payment of any such tax, levy, assessment, tariff, duty, deficiency, or fee, (b) any liability for the payment of any amounts of the type described in (a) as a result of being a member of a consolidated, combined, unitary or aggregate
group for any taxable period, and (c) any liability for the payment of any amounts of the type described in (a) or (b) as a result of being a transferee or successor to any Person or as a result of any express or implied obligation to
indemnify any other Person. 
 “Tax Contest” means any examination, investigation, audit or other proceeding in
respect of any Tax Return or Taxes involving the Company. 
 “Tax Return” or “Tax Returns”
means any return (including any information return), report, statement, schedule, notice, form, declaration, claim for refund or other document or information (including any attachment thereto and any amendment thereof) filed with or submitted to,
or required to be filed with or submitted to, any Governmental Authority in connection with the determination, assessment, collection or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with
any Law relating to any Tax. 
  

 9. 

 “Transaction Expenses” means any and all expenses, fees, commissions,
compensation or other amounts incurred by the Company or the shareholders of the Company, that are payable by the Company as a result of or in connection with the consummation of the transactions contemplated by this Agreement. 
 “Transfer Taxes” means all transfer, sales, real property or personal property transfer or gains, use, excise, stock transfer,
stamp, documentary, filing, recording, registration, and similar Taxes incurred as a result of the transactions contemplated by this Agreement. 
 Section 1.02 Terms Generally. Words in the singular shall be interpreted to include the plural and vice versa and words of one gender shall be interpreted to include the other gender as the context requires; the terms
“hereof,” “herein” and “herewith” and words of similar import shall, unless otherwise stated, be construed to refer to this Agreement and not to any particular provision of this Agreement; Article, Section, Exhibit and
Schedule references are to the Articles, Sections, Exhibits and Schedules to this Agreement unless otherwise specified; the word “including” and words of similar import when used in this Agreement shall mean “including, without
limitation,” unless otherwise specified; and, unless otherwise specified, all mathematical calculations shall be rounded to the fifth decimal place. 
 ARTICLE II 
 THE MERGER 
 Section 2.01 The Merger. At the Effective Time (as defined herein), and subject to and upon the terms and conditions of this Agreement and
the applicable provisions of the CGCL, Merger Sub shall be merged with and into the Company, the separate corporate existence of Merger Sub shall cease, and the Company shall continue as the surviving corporation and as a wholly owned subsidiary of
Purchaser. The surviving corporation after the Merger is sometimes referred to hereinafter as the “Surviving Corporation.” The corporate existence of the Company, with all its purposes, rights, privileges, franchises, powers
and objects, shall continue unimpaired by the Merger. 
 Section 2.02 Effective Time. Unless this Agreement is earlier terminated
pursuant to Section 10.01 hereof, the closing of the Merger (the “Closing”) will take place as promptly as practicable after the execution and delivery hereof by the parties, but no later than two (2) Business Days
following satisfaction or waiver of the conditions set forth in Articles VII and VIII hereof (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the fulfillment or waiver of those conditions), at the
offices of Fulbright & Jaworski L.L.P., 666 Fifth Avenue, New York, New York, unless another time or place is mutually agreed upon by Purchaser and the Company. The date upon which the Closing actually occurs shall be referred to herein as
the “Closing Date.” On the Closing Date, the parties hereto shall cause the Merger to be consummated by filing a certificate of merger, in substantially the form attached hereto as Exhibit 2.02, with the Secretary of
State of the State of California (the “Certificate of Merger”), in accordance with the applicable provisions of the CGCL (the date and time the Merger becomes effective shall be referred to herein as the “Effective
Time”). 
  

 10. 

 Section 2.03 Effect of the Merger. At the Effective Time, the effect of the Merger shall be
as provided in the applicable provisions of the CGCL, except as otherwise agreed pursuant to the terms of this Agreement. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all the property, rights,
privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all debts, liabilities, obligations, restrictions, disabilities and duties of the Company and Merger Sub shall become the debts,
liabilities, obligations, restrictions, disabilities and duties of the Surviving Corporation. 
 Section 2.04 Articles of
Incorporation and By-laws. 
 (a) The articles of incorporation of the Surviving Corporation shall be amended and restated in their
entirety to be identical to the form attached hereto as Exhibit 2.04(a), until thereafter amended in accordance with the CGCL and as provided in such articles of incorporation. 
 (b) The by-laws of the Surviving Corporation shall be amended and restated in their entirety to be identical to the form attached hereto as
Exhibit 2.04(b), until thereafter amended in accordance with the CGCL and as provided in the articles of incorporation of the Surviving Corporation and such by-laws. 
 Section 2.05 Directors and Officers. 
 (a) The directors of Merger Sub immediately prior to the Effective Time shall be the directors of the Surviving Corporation immediately after the Effective Time, each to hold the office of a director of the Surviving Corporation in
accordance with the provisions of the CGCL and the articles of incorporation and by-laws of the Surviving Corporation until their successors are duly elected and qualified, or until their earlier resignation or removal. The directors of the Company
immediately prior to the Effective Time shall cease to serve as directors immediately after the Effective Time. 
 (b) The officers of
Merger Sub immediately prior to the Effective Time shall be the officers of the Surviving Corporation immediately after the Effective Time, each to hold office in accordance with the provisions of the by-laws of the Surviving Corporation and at the
pleasure of the board of directors of the Surviving Corporation. 
 Section 2.06 Effect of Merger on the Capital Stock of the
Constituent Corporations. On the terms and subject to the conditions of this Agreement, the following shall occur: 
 (a) Conversion of
Company Capital Stock. Subject to Section 2.07 hereof, at the Effective Time, each outstanding share of Company Capital Stock (other than shares of Company Capital Stock held directly or indirectly by Purchaser, Merger Sub or the Company,
which shares will be cancelled and cease to exist) will be converted automatically, without any action on the part of Purchaser, Merger Sub, the Company or any holder thereof, into the right to receive the following: 
 (i) Each share of Company Preferred Stock shall be converted into the right to receive (A) such number of shares of Purchaser Common Stock as
is equal to the 

  

 11. 

 
Preferred Stock Liquidation Amount for such share, divided by $22.29 (the aggregate number of shares of Purchaser Common Stock into which all shares
of Company Preferred Stock are converted pursuant to this Section 2.06(a)(i)(A) is referred to as the “Preferred Stock Liquidation Shares”) plus (B) such number of shares of Purchaser Common Stock as is equal
to the number of shares of Company Common Stock into which such share of Company Preferred Stock is then convertible in accordance with the Restated Articles (which, for the sake of clarity, excludes accrued but unpaid dividends), multiplied
by the Exchange Ratio. 
 (ii) Each share of Company Common Stock shall be converted into the right to receive such number of
shares of Purchaser Common Stock as is equal to one, multiplied by the Exchange Ratio. 
 (b) Capital Stock of Merger Sub. Each
issued and outstanding share of capital stock of Merger Sub shall continue to be issued and outstanding and, by virtue of the Merger, and without any action on the part of the Purchaser, shall be automatically converted into one validly issued,
fully paid and non-assessable share of the capital stock of the Surviving Corporation. Each stock certificate evidencing ownership of any such share of Merger Sub shall thereupon evidence ownership of such shares of capital stock of the Surviving
Corporation. 
 (c) Company Options and Company Warrants. At the Effective Time, each outstanding Company Option and Company Warrant
that does not by its terms terminate as of or immediately prior to the Effective Time shall, to the extent such Company Option or Company Warrant is unexercised immediately prior to the Effective Time, be assumed by the Purchaser on the terms and
subject to the conditions set forth in this Agreement. Each such Company Option and Company Warrant shall continue to have, and be subject to, the same terms and conditions as are in effect immediately prior to the Effective Time (including, if
applicable, vesting terms and the other terms and conditions set forth in any equity incentive plan pursuant to which any Company Option was granted, or any option or warrant agreement documenting any Company Option or Company Warrant), except that
(i) such Company Option or Company Warrant shall be exercisable for that number of whole shares of Purchaser Common Stock as is equal to the product (rounded down to the nearest whole number, with no cash being paid for any fractional share
eliminated by such rounding) of the number of shares of Company Common Stock that were covered by such Company Option or Company Warrant immediately prior to the Effective Time, multiplied by the Exchange Ratio, and (ii) the per share
exercise price under such assumed option or warrant shall be equal to the quotient (rounded up to the nearest whole cent) obtained by dividing the per share exercise price under such option or warrant immediately prior to the Effective Time by the
Exchange Ratio. 
 (d) Fractional Shares. No fraction of a share of Purchaser Common Stock shall be issued in connection with the
Merger, but in lieu thereof each holder of shares of Company Capital Stock who would otherwise be entitled to a fraction of a share of Purchaser Common Stock (after aggregating for each particular holder all fractional shares to be received by such
holder) shall receive from Purchaser an amount of cash (rounded to the nearest whole cent) equal to the product of (i) such fraction and (ii) $22.29. 
 (e) Escrow Amount. Notwithstanding anything in this Agreement to the contrary, such number of shares of Purchaser Common Stock as is equal to fifteen percent (15%)

  

 12. 

 
of the Merger Consideration issuable to holders of Company Capital Stock (the “Escrow Fund”), and for the avoidance of doubt,
excluding any shares of Purchaser Common Stock issuable upon the exercise of each Company Option and Company Warrant that is assumed by Purchaser hereunder, shall be withheld and placed in escrow with the Escrow Agent and disbursed in accordance
with the Escrow Agreement. The costs and expenses of establishing and maintaining the Escrow Agreement shall be borne by Purchaser. 
 (f)
Payment of the Merger Consideration to the Persons and in the amounts set forth in this Section 2.06 will be deemed to satisfy the terms of the Restated Articles applicable to the transactions contemplated hereby, even if a class or series
of shares is to have distributed to it a lesser amount than would be required by the Restated Articles. 
 Section 2.07 Dissenting
Shares. Notwithstanding anything in this Agreement to the contrary, shares of Company Capital Stock issued and outstanding immediately prior to the Effective Time and held by a holder who has not voted in favor of the Merger or consented thereto
in writing in accordance with the CGCL, whose appraisal rights were perfected in accordance with Chapter 13 of the CGCL (“Chapter 13”) and who has complied with the other relevant provisions of Chapter 13
(“Dissenting Shares”) shall not be converted into or be exchangeable for the right to receive the Merger Consideration as provided in Section 2.06(a) and instead such holder of Dissenting Shares shall be entitled to
receive payment in accordance with the provisions of Chapter 13 unless and until such holder fails to perfect or withdraws or otherwise loses his right to appraisal and payment under Chapter 13. If, after the Effective Time, any such holder fails to
perfect or withdraws or loses his right to appraisal, such Dissenting Shares shall thereupon be treated as if they had been converted as of the Effective Time into the right to receive the Merger Consideration to which such holder would have been
entitled but for the prior status of such shares as Dissenting Shares, without interest or dividends thereon, upon surrender in the manner provided in Section 2.08 of the certificate(s) which formerly represented such shares. The Company shall
give Purchaser (i) prompt notice of any demands for appraisal received by the Company, withdrawals of such demands, and any other related communications received by the Company and (ii) the right to direct all negotiations and proceedings
with respect to demands for appraisal under Chapter 13. The Company shall not, except with the prior written consent of Purchaser, voluntarily make any payment or offer to make any payment with respect to, or settle or offer to settle, any claim or
demand in respect of any Dissenting Shares. 
 Section 2.08 Exchange of Certificates. 
 (a) Letter of Transmittal. Prior to the Effective Time, Purchaser shall prepare a form of letter of transmittal which shall be reasonably
acceptable to the Company (the “Letter of Transmittal”) and instructions for effecting the surrender of the certificates formerly representing shares of Company Capital Stock (the “Certificates”) in
exchange for certificates representing shares of Purchaser Common Stock. The Letter of Transmittal shall (i) appoint the Shareholder Representative as attorney and agent-in-fact in accordance with Section 2.09, (ii) contain a standard
“lock-up” with respect to the shares of Purchaser Common Stock being issued, (iii) specify that delivery of Certificates shall be effected (and risk of loss and title shall pass) only upon delivery of Certificates to the Purchaser and
(iv) otherwise be in such form and have such customary provisions as the Company or Purchaser may reasonably request. 
  

 13. 

 (b) Exchange Procedures. At or following the Closing, upon surrender of a Certificate for
cancellation to the Purchaser, together with a duly executed Letter of Transmittal, the holder of such Certificate shall be entitled to receive in exchange therefor (i) a certificate or certificates representing that whole number of shares of
Purchaser Common Stock which such holder has the right to receive pursuant to Section 2.06(a) and (ii) payment by check of funds in U.S. dollars representing the amount of cash in lieu of fractional shares, if any, which such holder has
the right to receive pursuant to the provisions of this Article II. The shares represented by a Certificate so surrendered shall forthwith be cancelled. As soon as practicable after the Effective Time, the Purchaser shall mail the Letter of
Transmittal and instructions to the holder of record of each Certificate that was not surrendered at the Closing. In the event of a transfer of ownership of shares of Company Capital Stock that is not registered on the transfer records of the
Company, a certificate representing the proper number of shares of Purchaser Common Stock, together with a check for the cash to be paid in lieu of fractional shares, if any, may be issued to such transferee if the Certificate representing such
shares of Company Capital Stock held by such transferee is presented to the Purchaser, accompanied by all documents required to evidence and effect such transfer and to evidence that any applicable stock transfer Taxes have been paid. Until
surrendered as contemplated by this Section 2.08(b), each Certificate shall be deemed at any time after the Effective Time to represent only the right to receive upon surrender a certificate representing shares of Purchaser Common Stock and
cash in lieu of fractional shares, as provided in this Article II. If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed
and, if required by the Purchaser, the granting by such Person of a contractual indemnity or the posting by such Person of a bond in such reasonable amount as the Purchaser may direct as indemnity against any claim that may be made against it with
respect to such Certificate, the Purchaser will deliver in exchange for such lost, stolen or destroyed Certificate, a certificate representing the proper number of shares of Purchaser Common Stock, together with a check for the cash to be paid in
lieu of fractional shares, if any, with respect to the shares of Company Capital Stock formerly represented thereby. 
 (c) Distributions
with Respect to Unexchanged Shares. No dividends or other distributions declared or made after the Effective Time with respect to shares of Purchaser Common Stock having a record date after the Effective Time shall be paid to the holder of any
unsurrendered Certificate, and no cash payment in lieu of fractional shares shall be paid to any such holder, until the holder shall surrender such Certificate as provided in this Section 2.08. No interest will be paid or accrued on the cash in
lieu of fractional shares, if any, or on unpaid dividends and distributions, if any. 
 (d) No Further Ownership Rights in Company Capital
Stock. At the Effective Time, the stock transfer books of the Company shall be closed and thereafter there shall be no further registration of transfers of shares of Company Capital Stock on the records of the Company. From and after the
Effective Time, except for Purchaser and Merger Sub, the holders of shares of Company Capital Stock outstanding immediately prior to the Effective Time shall cease to have any rights as a shareholder with respect to such shares except as provided by
applicable Law, and all certificates of Purchaser Common Stock and cash in lieu of fractional shares delivered pursuant to this Article II upon the surrender or exchange of Certificates shall be deemed to have been delivered in full satisfaction of
all rights pertaining to the shares of Company Capital Stock theretofore represented by such Certificate. 
  

 14. 

 (e) No Liability. Neither Purchaser nor the Surviving Corporation shall be liable to any person in
respect of any shares of Purchaser Common Stock (or dividends or distributions with respect thereto) or cash delivered to a public official pursuant to any applicable abandoned property, escheat or similar law. If any Certificates shall not have
been surrendered prior to seven years after the Effective Time (or immediately prior to such earlier date on which any cash in lieu of fractional shares or any dividends or distributions with respect to whole shares of Purchaser Common Stock in
respect of such Certificate would otherwise escheat to or become the property of any Governmental Authority), any such cash, dividends or distributions in respect of such Certificate shall, to the extent permitted by applicable Law, become the
property of the Purchaser, free and clear of all claims or interest of any Person previously entitled thereto. 
 (f) Withholding.
Purchaser, the Company, Merger Sub and the Surviving Corporation, as the case may be, shall be entitled to deduct and withhold from the Merger Consideration otherwise payable pursuant to this Agreement such amounts that Purchaser, the Company,
Merger Sub or the Surviving Corporation is required to deduct and withhold under the Code, the rules and regulations promulgated thereunder or any provision of state, local or foreign Tax Law with respect to the making of such payment. To the extent
that amounts are so withheld, such amounts shall be treated for all purposes as having been paid to the holder of Company Capital Stock, Company Options or Company Warrants in respect of which such deduction and withholding was made. 
 Section 2.09 Shareholder Representative. The Shareholder Representative is hereby appointed as agent and attorney-in-fact, for and on behalf
of each holder of Company Capital Stock, Company Options and Company Warrants (collectively, the “Holders”), to give and receive notices and communications, to authorize payment to Purchaser from the Escrow Fund in
satisfaction of any Loss (as herein defined) suffered or incurred by a Purchaser Indemnified Party (as herein defined) pursuant to Section 9.02, to object to such payments, to agree to, negotiate, enter into settlements and compromises of, and
comply with orders of courts with respect to such claims and to take all other actions that are either (i) necessary or appropriate in the judgment of the Shareholder Representative for the accomplishment of the foregoing or
(ii) specifically mandated by the terms of this Agreement. A decision, act or consent of, or instruction from the Shareholder Representative shall constitute a decision of the Holders, and shall be final, binding and conclusive upon the
Holders; and Purchaser and the Escrow Agent may rely upon any such decision, act or consent of, or instruction from, the Shareholder Representative as being the decision, act or consent of, or instruction from, the Holders. The Escrow Agent,
Purchaser and the Surviving Corporation are hereby relieved from any liability to any Person for any acts done by them in accordance with such decision, act or consent of, or instruction from, the Shareholder Representative. The Shareholder
Representative may be changed by the Holders from time to time upon not less than ten (10) days’ prior written notice to the Escrow Agent and Purchaser; provided that a Shareholder Representative may not be removed unless Holders of
a majority in interest of the Escrow Fund agree to such removal and to the identity of the substituted agent. The Shareholder Representative shall not be liable for any act done or omitted hereunder or under the Escrow Agreement as Shareholder
Representative absent bad faith or gross negligence. In all questions arising hereunder or under the Escrow Agreement, the Shareholder Representative may rely on the advice of counsel, and will not be liable to the Holders or any other person or
party for anything done, omitted or suffered in good faith by the Shareholder Representative based on such advice. The Holders by 

  

 15. 

 
or on whose behalf the Escrow Fund will be contributed shall severally indemnify the Shareholder Representative and hold the Shareholder Representative
harmless against any loss, liability or expense incurred without gross negligence or bad faith on the part of the Shareholder Representative and arising out of or in connection with the acceptance or administration of the Shareholder
Representative’s duties hereunder or under the Escrow Agreement, including the reasonable fees and expenses of any legal counsel retained by the Shareholder Representative. Prior to the Closing, the Company may prepay the costs and expenses of
the Shareholder Representative in an amount not to exceed $75,000, $25,000 of which shall cover expenses associated with the engagement of the Shareholder Representative and $50,000 of which shall cover any expenses incurred by the Shareholder
Representative in connection with fulfilling its obligations under this Agreement and the Escrow Agreement. Any portion of such $50,000 remaining unspent by the Shareholder Representative upon the completion of its duties pursuant to this Agreement
and the Escrow Agreement shall be paid by the Shareholder Representative to the Purchaser in cash. Any amounts spent by the Shareholder Representative pursuing or defending any claims pursuant to Article IX hereof finally determined adversely, in
accordance with the provisions of this Agreement, to the parties represented by the Shareholder Representative in such action shall be paid to the Purchaser out of the Escrow Fund, which shares shall be valued at the Purchaser Stock Price.

 Section 2.10 Securities Act Exemption. The Purchaser Common Stock to be issued in the Merger is intended to be exempt from the
registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(2) of the Securities Act and from applicable state securities laws. The Company will use reasonable
efforts to facilitate its shareholders taking all reasonable actions and executing all necessary documents to qualify the issuance of Purchaser Common Stock for such exemptions. Without limiting the generality of the foregoing, the Company will use
reasonable efforts to facilitate the Purchaser Common Stock to be issued in the Merger being exempt from the registration requirements of the Securities Act pursuant to Rule 506 promulgated thereunder, including using reasonable efforts to
facilitate the appointment of a “purchaser representative” on behalf of the Company’s shareholders who are not “accredited investors,” as such terms are defined in Rule 501 promulgated under the Securities Act. For the
avoidance of doubt, reliance on Section 4(2) of the Securities Act without complying with the requirements of Regulation D promulgated thereunder shall be sufficient to comply with the requirements of this Section 2.10 and shall not give
rise to any termination right of either party hereunder. 
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 The Company represents and warrants to the Purchaser that the statements contained in this Article III are true, correct and complete as of the date of
this Agreement and will be true, correct and complete as of the Closing Date (as though made then and as though the Closing Date were substituted for the date of this Agreement throughout this Article III), except as set forth in the Company
Disclosure Schedule. Nothing in the Company Disclosure Schedule shall be deemed adequate to disclose an exception to a representation or warranty made herein, however, unless the Company Disclosure Schedule identifies the exception with reasonable
particularity and describes the relevant facts in reasonable detail. The Company Disclosure 

  

 16. 

 
Schedule will be arranged in paragraphs corresponding to the lettered and numbered paragraphs contained in this Article III; provided, however, that
any information disclosed therein under any section number shall be deemed to be disclosed and incorporated in any other section of the Company Disclosure Schedule where such disclosure would be appropriate and reasonably apparent from the
description in the Company Disclosure Schedule. Disclosure of any information or document in the Company Disclosure Schedule shall not be deemed a statement or admission that it is material or required to be disclosed therein. 
 Section 3.01 Organization, Etc. The Company is a corporation duly organized, validly existing and in good standing under the laws of the
State of California. The Company is duly qualified or licensed to do business, and is in good standing, as a foreign company in each jurisdiction where the character of the Assets or the nature of its activities makes such qualification or licensing
necessary except where the failure to so qualify or be licensed would not have a Company Material Adverse Effect, all of which jurisdictions are set forth on the Company Disclosure Schedule. The Company has full power and authority to conduct its
business as it is now being conducted and to own, operate or lease the Assets. The Company has heretofore delivered to the Purchaser true and correct copies of its articles of incorporation and by-laws as in effect on the date hereof. The Company
has all requisite power and authority to enter into this Agreement and each of the Ancillary Agreements to which it is a party, to carry out its obligations under this Agreement and each of the Ancillary Agreements to which it is a party and to
consummate the transactions contemplated hereby and thereby. 
 Section 3.02 Capitalization. The authorized, issued and
outstanding shares of Company Capital Stock are as set forth in Section 3.02 of the Company Disclosure Schedule and are held of record (and, to the Knowledge of the Company, beneficially) by the Persons and in the amounts and classes or series
of shares as set forth in Section 3.02 of the Company Disclosure Schedule. All outstanding shares of Company Capital Stock are, and all shares reserved for issuance will be, upon issuance in accordance with the terms specified in the
instruments or Contracts pursuant to which they are issuable, duly authorized, validly issued, fully paid and non-assessable. None of the outstanding shares of Company Capital Stock are subject to preemptive rights created by statute, the Restated
Articles or any Contract to which the Company is a party or by which it is bound. Other than as disclosed in Section 3.02 of the Company Disclosure Schedule with respect to the Company Preferred Stock, there are no declared or accrued but
unpaid dividends with respect to any shares of Company Capital Stock. The designations, powers, preferences, rights, qualifications, limitations and restrictions in respect of the Company Capital Stock are as set forth in the Restated Articles and
the Company’s by-laws, and all such designations, powers, preferences, rights, qualifications, limitations and restrictions are valid, binding and enforceable in accordance with all applicable Law. None of such outstanding shares of Company
Capital Stock has been issued in violation of any preemptive rights, rights of first refusal or similar rights. Section 3.02 of the Company Disclosure Schedule sets forth a complete and correct list of the holders of all Company Options and
Company Warrants outstanding as of the date hereof, including: (a) the date of grant or issuance; (b) the exercise price; (c) the vesting schedule and expiration date; and (d) any other material terms, including any terms
regarding the acceleration of vesting. No Company Option (i) has a per share exercise price lower than the fair market value of one share of the Company Capital Stock underlying such option on the date of grant of such Company Option as
determined in good faith by the board of directors of the Company, or (ii) has had its grant date 

  

 17. 

 
backdated. Except as set forth in Section 3.02 of the Company Disclosure Schedule, there are no outstanding options, warrants, convertible securities,
calls, rights, commitments, preemptive rights or agreements or instruments or understandings of any character to which the Company is a party or by which the Company is bound, obligating the Company to issue, deliver or sell, or cause to be issued,
delivered or sold, contingently or otherwise, additional capital stock or any securities or obligations convertible into or exchangeable for such capital stock or to grant, extend or enter into any such option, warrant, convertible security, call,
right, commitment, preemptive right or agreement. There are no voting trust agreements or other Contracts or understandings restricting or otherwise relating to voting, dividend or other rights with respect to the capital stock of the Company. The
Company does not have any Subsidiaries and does not own, directly or indirectly, any capital stock or other equity interest in any corporation, partnership, joint venture or other entity. Payment of the Merger Consideration to the Persons and in the
amounts set forth in Section 2.06 will satisfy the terms of the Restated Articles applicable to the transactions contemplated hereby based on the value of the Purchaser Common Stock as set forth herein. 
 Section 3.03 Authorization. The board of directors of the Company, at a meeting duly called and held, duly and unanimously adopted
resolutions declaring that this Agreement, the Ancillary Agreements, the Merger and the transactions contemplated hereby and thereby are in the best interests of its shareholders and recommending that its shareholders approve this Agreement, the
Ancillary Agreements, the Merger and the transactions contemplated hereby and thereby. The Shareholder Approval is the only vote of holders of any class or series of capital stock or other securities of the Company necessary to approve this
Agreement, the Ancillary Agreements, the Merger and the transactions contemplated hereby and thereby. Subject to obtaining the Shareholder Approval, the execution and delivery by the Company of this Agreement and the Ancillary Agreements to which it
is party, the performance by the Company of its obligations hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all requisite action on the part of the Company and its
shareholders. This Agreement has been, and each Ancillary Agreement to which the Company is a party will be, duly executed and delivered by the Company and (assuming due authorization, execution and delivery by the other parties thereto) this
Agreement is, and each Ancillary Agreement to which the Company is a party, when so duly executed and delivered will be, a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms (except as
the enforceability thereof may be limited by any applicable bankruptcy, insolvency or other Laws affecting creditors’ rights generally or by general principles of equity, regardless of whether such enforceability is considered in equity or at
law). 
 Section 3.04 No Violation. Subject to obtaining the Shareholder Approval, the execution, delivery and performance of
this Agreement and the Ancillary Agreements do not and will not (a) violate or conflict with the articles of incorporation or by-laws of the Company, (b) conflict with or violate any Law or Governmental Order applicable to the Company, or
(c) result in any breach of, or constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under, or give to any Person any rights of termination, amendment, acceleration or cancellation
of, or give to any Person any additional rights or entitlement to increased, additional, accelerated or guaranteed payments under, or result in the loss of any benefit under or result in the creation of any Lien on any of the Assets pursuant to,

  

 18. 

 
any Contract, License or other instrument to which the Company is a party or by which any of the Assets are bound or affected, except for Liens created by or
through the Purchaser or any of its Affiliates. 
 Section 3.05 Approvals. Subject to obtaining the Shareholder Approval, the
execution and delivery of this Agreement and the Ancillary Agreements by the Company do not, and the performance of this Agreement and the Ancillary Agreements by the Company will not, require any consent, approval, authorization or other action by,
or filing with or notification to, any Governmental Authority or other Person under any Law or Contract. 
 Section 3.06 Financial
Statements and Other Information. 
 (a) True, correct and complete copies of the Company’s unaudited balance sheets as of
December 31, 2005, 2006 and 2007 and the related unaudited statements of operations and cash flows for the years then ended (collectively, the “Company Financial Statements”) are set forth in Section 3.06 of the
Company Disclosure Schedule. The unaudited balance sheet of the Company as of December 31, 2007 is referred to as the “Company Balance Sheet”. 
 (b) The Company Financial Statements are in accordance with the books and records of the Company and have been prepared in accordance with GAAP
consistently applied throughout the periods covered thereby, and the balance sheets included therein present fairly as of their respective dates the financial condition of the Company. All liabilities and obligations, whether absolute, accrued,
contingent or otherwise, whether direct or indirect, and whether due or to become due, which existed at the date of the Company Balance Sheet have been disclosed in the Company Balance Sheet to the extent such liabilities were required, under GAAP,
to be so disclosed. The statements of operations and cash flows included in the Company Financial Statements present fairly the results of operations and cash flows of the Company for the periods indicated. The statements of operations included in
the Company Financial Statements do not contain any material items of special or non-recurring income or other income not earned, or omit any expenses incurred, in the ordinary course of business except as expressly specified therein. The statements
of operations and cash flows included in the Company Financial Statements reflect all costs that have historically been incurred by the Company. The Company’s business has not been conducted through any Person other than the Company.

 (c) The accounts receivable of the Company as set forth on the Company Balance Sheet or arising since the date thereof are valid
and genuine; have arisen solely out of bona fide sales and deliveries of goods, performance of services and other business transactions in the ordinary course of business consistent with past practice; are not subject to valid defenses, set-offs or
counterclaims; and, except as set forth in the Company Disclosure Schedule, are collectible at the full recorded amount thereof (less, in the case of accounts receivable appearing on the Company Balance Sheet, the recorded allowance for collection
losses on the Company Balance Sheet) over the period of usual trade terms (by use of the Company’s normal collection methods without resort to litigation or reference to a collection agency). The allowance for collection losses on the Company
Balance Sheet has been determined in accordance with GAAP consistent with past practice. 
  

 19. 

 (d) Except as set forth in the Company Disclosure Schedule, the liabilities on the Company Balance
Sheet consist solely of accrued obligations and liabilities incurred by the Company in the ordinary course of business to Persons which are not Affiliates of the Company. There are no liabilities of the Company of any kind whatsoever, whether or not
accrued and whether or not contingent or absolute, determined or determinable or otherwise, including, without limitation, documentary or standby letters of credit, bid or performance bonds, or customer or third party guarantees, and no existing
condition, situation or set of circumstances that could reasonably result in such a liability, other than (i) liabilities disclosed in the Company Financial Statements, and (ii) liabilities which have arisen after the date of the Company
Balance Sheet in the ordinary course of business and consistent with past practice (none of which is a liability for breach of contract, breach of warranty, tort, infringement claim or lawsuit) which liabilities, individually or in the aggregate,
are not material. 
 (e) The books, records and accounts of the Company accurately and fairly reflect, in reasonable detail, the
transactions and the assets and liabilities of the Company. The Company has not engaged in any transaction with respect to its business, maintained any bank account for its business or used any of the funds of the Company, except for transactions,
bank accounts and funds which have been and are reflected in the normally maintained books and records of the Company. 
 (f) The
Company Disclosure Schedule lists the name and address of every bank and other financial institution in which the Company or its Affiliates maintain an account (whether checking, savings or otherwise), lock box or safe deposit box, and the account
numbers and names of persons having signing authority or other access thereto. 
 Section 3.07 Absence of Certain Changes or
Events. 
 (a) Since December 31, 2007, except as contemplated by this Agreement, the Company has conducted its business in
all material respects in the ordinary course consistent with past practice. Since December 31, 2007, there has been no material adverse change in the Assets or liabilities, or in the business, condition (financial or otherwise) or results of
operations, of the Company, whether as a result of any legislative or regulatory change, revocation of any License or right to do business, fire, explosion, accident, casualty, labor trouble, flood, drought, riot, storm, condemnation or act of God
or otherwise, and, to the Knowledge of the Company, no fact or condition exists or is contemplated or threatened which would reasonably be anticipated to cause such a change in the future. 
 (b) Without limiting the generality of the foregoing, since December 31, 2007, except as contemplated by this Agreement, the Company has not:

 (i) except in the ordinary course of business consistent with past practice granted any Lien (other than a Permitted Lien) on any
Asset; 
 (ii) except for bonuses earned in 2007 under the Company’s incentive compensation plans not to exceed $360,000 in the
aggregate and the amendments to outstanding Company Options referenced in Section 5.03 hereof, granted or agreed to grant any bonus to any Company Employee or made any increase in the rate of salary or in the other compensation or benefits of
any Company Employee, or adopted or amended any Employee Benefit Plan or entered into any employment agreement or committed to do any of the foregoing; 
  

 20. 

 (iii) except for sales of inventory in the ordinary course of business and consistent with past
practice of the Company, sold, assigned, transferred, leased or otherwise disposed of any Assets having a value individually or in the aggregate exceeding $10,000; 
 (iv) except as required by GAAP, made any material change in any method of accounting or accounting practice relating to the Company; 
 (v) failed to pay or discharge when due any liability or obligation; 
 (vi) commenced any new lines of business; 
 (vii) paid or declared any dividend or other distribution with respect to any shares of capital stock; 
 (viii)
issued any shares of capital stock or other security (including, without limitation, securities convertible into or rights to acquire shares of capital stock of the Company); 
 (ix) borrowed any amount or incurred or become subject to any liability (absolute, accrued or contingent), except current liabilities incurred
and liabilities under Contracts entered into in the ordinary course of business; 
 (x) suffered any loss of any Asset or waived any
right of substantial value whether or not in the ordinary course of business; 
 (xi) received written notice of termination from any
of the suppliers or customers of the Company required to be disclosed pursuant to Section 3.19; 
 (xii) delayed or postponed
the payment of accounts payable and other liabilities; 
 (xiii) entered into any transaction affecting the Assets of the Company
except in the ordinary course of business; and 
 (xiv) except as contemplated by this Agreement, entered into any commitment or
Contract to do any of the foregoing. 
 Section 3.08 Taxes. Except as set forth in the Company Disclosure Schedule: 

(a) all Tax Returns required to be filed by or on behalf of the Company have been filed in a timely manner with the appropriate Governmental
Authorities in all jurisdictions in which such Tax Returns are required to be filed (taking into account all extensions); 
 (b) all
such Tax Returns and the information and data contained therein are true, correct and complete for the periods covered by such Tax Returns; 
  

 21. 

 (c) all Taxes (whether or not shown on any Tax Return) payable by the Company have been fully and
timely paid, and the cash reserves or accruals for unpaid Taxes provided in the books and records of the Company are sufficient for all unpaid Taxes of the Company for all periods through December 31, 2007; 
 (d) none of the Tax Returns of the Company are now under audit, investigation or examination by any Governmental Authority, there are no
agreements, waivers or other arrangements in force providing for an extension of time with respect to the assessment or collection of any Tax or deficiency of any nature with respect to any such Tax Return, nor is any Action now pending or in
progress or, to the Knowledge of the Company, threatened against the Company with respect to any Tax; 
 (e) no claim has been made in
writing by a Governmental Authority in a jurisdiction where Tax Returns concerning or relating to the Company or its income, operations, Assets or activities have not been filed that the Company is or may be subject to taxation by that jurisdiction;

 (f) the Company has withheld and paid to the appropriate Governmental Authorities all Taxes required to have been withheld and
paid, including Taxes withheld and paid in connection with amounts paid or owing to any shareholder, employee, independent contractor, creditor or other third party; 
 (g) there are no Liens for Taxes imposed by any Governmental Authority outstanding against any of the Assets or the Company except Liens for current Taxes not yet due and payable; 
 (h) no power of attorney enabling any Person to represent the Company with respect to any Tax matter is currently in force; 
 (i) the Company is not a party to or bound by any Tax allocation, Tax sharing or Tax indemnity Contract or similar arrangement with any other
party (whether or not written), and has no liability for the Taxes of any other Person as a transferee or successor, by Contract, or otherwise. 
 (j) the Company has never been included in any consolidated, combined, or unitary Tax Return; 
 (k) neither the
Company nor any other Person on behalf of or with respect to the Company has (i) agreed to or is required to make any adjustments pursuant to Section 481(a) of the Code or any similar provision of state, local or foreign Law by reason of a
change in accounting method initiated by the Company, and to the Company’s Knowledge, the Internal Revenue Service (“IRS”) has not proposed any such adjustment or change in accounting method, and there are no
applications pending with any Governmental Authority requesting permission for any changes in accounting methods that relate to the business or operations of the Company, (ii) executed or entered into a closing agreement pursuant to
Section 7121 of the Code or any predecessor provision thereof or any similar provision of state, local or foreign Law with respect to the Company or (iii) requested any extension of time within which to file any Tax Return concerning or
relating to the Company or its operations, which Tax Return has since not been filed; 
  

 22. 

 (l) the Company does not own any interest in any entity that is treated as a partnership for U.S.
federal income Tax purposes or would be treated as a pass-through or disregarded entity for any Tax purpose; 
 (m) the Company has
not constituted either a “distributing corporation” or a “controlled corporation” within the meaning of Section 355(a)(1)(A) of the Code in a distribution qualifying for tax-free treatment under Section 355 of the Code
(i) in the two years prior to the date of this Agreement or (ii) in a distribution that could otherwise constitute part of a “plan” or “series of transactions” (within the meaning of Section 355(e) of the Code) in
conjunction with this Agreement; 
 (n) the Company has not (i) “participated” in a “reportable transaction”
within the meaning of Treasury Regulations Section 1.6011-4 or (ii) taken any reporting position on a Tax Return, which reporting position (A) if not sustained, would be reasonably likely, absent disclosure, to give rise to a penalty
for substantial understatement of federal income Tax under Section 6662 of the Code (or any predecessor statute or any corresponding provision of any such statute or state, local or foreign Tax law), and (B) has not adequately been
disclosed on such Tax Return in accordance with Section 6662(d)(2)(B) of the Code (or corresponding provision of any such predecessor statute or state, local or foreign Tax law); 
 (o) (i) none of the Assets is “tax exempt use property” within the meaning of Section 168(h) of the Code, and (ii) none of the
Assets is a lease made pursuant to Section 168(f)(8) of the Internal Revenue Code of 1954, as amended and in effect immediately prior to the enactment of the Tax Reform Act of 1986; 
 (p) the Company has not been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the
applicable period specified in Section 897(c)(1)(A)(ii) of the Code; and 
 (q) The Company is not a party to any Contract that
has resulted or would result, separately or in the aggregate, in the payment of any “excess parachute payment” within the meaning of Section 280G of the Code (or any similar provision of state, local, or foreign Law). 
 (r) The Company has not taken or agreed to take any action, has not failed to take any action or knows of no fact, Contract, plan or other
circumstance that is reasonably likely to prevent the Merger from qualifying as a reorganization within the meaning of Section 368(a) of the Code. 
 Section 3.09 Litigation. Except as set forth in the Company Disclosure Schedule, there are no Actions pending or, to the Knowledge of the Company, overtly threatened against the Company or the Assets. With
respect to each Action described in the Company Disclosure Schedule, copies of all pleadings, filings, correspondence with opposing parties and their counsel, opinions of counsel, results of studies, judgments, orders, attachments, impositions of or
recordings of Liens and other documents have been furnished to the Purchaser. The Company is not subject to any Governmental Order. 
  

 23. 

 Section 3.10 Compliance with Laws. The Company has conducted its business in compliance in
all material respects with all Laws and Governmental Orders applicable to the Company. No investigation or review by any Governmental Authority with respect to the Company is pending or, to the Knowledge of the Company, overtly threatened, nor has
any Governmental Authority indicated in writing to the Company an intention to conduct the same. Neither the Company nor, to the Knowledge of the Company, any shareholder, director, officer, consultant or employee of the Company (in their capacity
as such), is in default in any material respect with respect to any Governmental Order. There is no existing Law which would prohibit or materially restrict or otherwise materially adversely affect the Company from conducting its business in any
jurisdiction in which it is now being conducted. 
 Section 3.11 Property. 
 (a) The Company owns no real property. 
 (b) Section 3.11(b) of the Company Disclosure Schedule identifies each real or personal property leased or subleased by the Company (the “Leased Property”). All leases and subleases with respect to such
Leased Property (the “Property Leases”) are subject to no Liens except Permitted Liens. 
 (c) True and
complete copies of the Property Leases have been made available to the Purchaser. Subject to the terms of the respective Property Leases, the Company has a valid and subsisting leasehold or subleasehold estate in each Leased Property. The Property
Leases are in full force and effect and neither the Company nor, to the Knowledge of the Company, any other party to any Property Lease is in default thereunder. 
 Section 3.12 Environmental Matters. Except as set forth in Section 3.12 of the Company Disclosure Schedule: (a) the Company has complied at all times in all material respects with all applicable
Environmental Laws; (b) to the Knowledge of the Company, no property currently or formerly owned or operated by the Company (including soils, groundwater, surface water, buildings or other structures) is contaminated with any Hazardous
Substance that could require remediation or result in liability pursuant to any Environmental Law; (c) the Company is not subject to material liability for any Hazardous Substance disposal or contamination by the Company on any third party
property; (d) the Company has not Released any Hazardous Substance; (e) the Company has not received any notice, demand, letter, material claim or request for information alleging that the Company may be in violation of or subject to
material liability under any Environmental Law; (f) the Company is not subject to any order, decree, injunction or other arrangement with any Governmental Authority or any indemnity or other agreement with any third party relating to material
liability or obligations concerning any Environmental Law or otherwise relating to any Hazardous Substance; (g) there are no other circumstances or conditions involving the Company that are reasonably likely to result in any material claim,
material liability, investigation, cost or restriction on the ownership, use, or transfer of any property pursuant to any Environmental Law; and (h) the Company has made available to Purchaser copies of all written environmental reports,
studies, assessments, sampling data and any other material environmental information in its possession relating to the Company or its respective current and former properties or operations. 
  

 24. 

 Section 3.13 Condition of the Assets and Related Matters. 
 (a) The Assets will, as of the Closing Date, constitute all of the assets (other than human capital) necessary for the conduct of the
Company’s business in all material respects as currently conducted. 
 (b) The Assets are in good operating condition, ordinary
wear and tear excepted, are usable in the ordinary course of business, are adequate and suitable for the uses to which they are being put and conform in all material respects to all applicable Laws relating to their construction, use and operation.
None of the Assets are in need of maintenance or repairs other than ordinary routine maintenance and repairs which are not material, individually or in the aggregate, in nature or cost. 
 Section 3.14 Employee Plans and Labor Matters. 
 (a) Section 3.14(a) of the Company Disclosure Schedule lists each “employee benefit plan,” as defined in Section 3(3) of ERISA, whether or not subject to ERISA, and each other employment,
severance, termination, change in control, incentive, retention, deferred compensation, stock option or other equity-related, fringe benefit, vacation, sick pay, life insurance or other compensatory plan, program, policy, agreement or arrangement
that is (i) maintained or contributed to by the Company or with respect to which the Company is obligated to contribute and (ii) either (A) covers any current or former employee, director or consultant, or any beneficiary or dependent
of any of the foregoing or (B) with respect to which the Company could reasonably be expected to have any liability (each an “Employee Plan” and, together, the “Employee Plans”). 
 (b) The Company has delivered or made available to Parent, with respect to each Employee Plan, true and complete copies of the governing documents
for the plan and for any related funding vehicle, including any amendments thereto, and, where applicable, (i) any summary plan descriptions and summaries of material modifications, (ii) the annual report on Form 5500, the Form PBGC-1
filing, the annual accounting report and the annual actuarial valuation report, in each case for the two most recent plan years, and (iii) the most recent IRS favorable determination or opinion letter and any pending application for a
determination letter or opinion letter. 
 (c) No Employee Plan is subject to Section 412 of the Code or Title IV of ERISA and
neither the Company nor any entity that, together with the Company, would be treated as a single employer under Section 414 of the Code (an “ERISA Affiliate”) has sponsored, maintained or contributed to, or had any
obligation to sponsor, maintain or contribute to, any employee benefit plan subject to Title IV of ERISA. No Employee Plan is a “multiemployer plan” as that term is defined in Section 3(37) of ERISA and neither the Company nor any
ERISA Affiliate has contributed to or been obligated to contribute to a multiemployer plan. No Employee Plan covers solely or primarily employees of the Company or any ERISA Affiliate who reside permanently outside the United States. 
  

 25. 

 (d) Each Employee Plan has been maintained and administered in all material respects in compliance
with its terms and applicable Law. The Company has timely made all payments, contributions and deposits required to be made by it under or in connection with each Employee Plan. There are no pending or overtly threatened claims, proceedings or
demands (other than routine claims for benefits) under or with respect to any Employee Plan and, to the Company’s Knowledge, no facts exist which could be reasonably expected to give rise to any such claims, proceedings or demands. With respect
to each Employee Plan which is a group health plan within the meaning of Section 5000(b)(1) of the Code, (i) the Company has complied in all material respects with the provisions of Section 4980B of the Code; and (ii) no event
has occurred and no circumstance exists under which the Company has incurred or may incur, direct or indirect liability by reason of a failure to comply with the requirements of Section 4980B of the Code which could become a liability of the
Purchaser. Except as may be required under the Consolidated Omnibus Budget Reconciliation Act of 1985 (within the meaning of Code Section 4980B), the Company has no obligation to provide or make available post-employment health or other welfare
benefits or coverage for any current or former employee, director or other personnel. No compensation paid or required to be paid under any Employee Plan was, is or will be subject to additional tax under Section 409A(1)(B) of the Code or
non-deductible by reason of Section 280G of the Code. 
 (e) Neither the Company nor any of its ERISA Affiliates has used
services or workers provided by third party contract labor suppliers, temporary employees, leased employees, or individuals who have provided services as independent contractors to an extent that would reasonably be expected to result in the
disqualification of any Employee Plan or the imposition of penalties or excise taxes with respect to any Employee Plan by the IRS, the Department of Labor or any other Governmental Authority. 
 (f) Labor Matters. The schedule previously provided by the Company to Purchaser contains a true and complete list of all Company employees (the
“Company Employees”) and all other persons who are performing services for the Company on the date hereof, indicating for each the title and rate of compensation, and the amount of any accrued bonuses, vacation, sick leave,
maternity leave and other leave as of the date of this Agreement. There are thirty (30) full-time Company Employees (those who are regularly scheduled to work 20 or more hours per week), three (3) part-time Company Employees (those who are
regularly scheduled to work less than 20 hours per week), one (1) temporary Company Employee, no leased Company Employees and three (3) independent contractors. The Company is not in default with respect to any withholding or other
employment Taxes or payments with respect to accrued vacation or severance pay on behalf of any employee or independent contractor for which it is obligated on the date hereof, and the Company will maintain and continue to make all such necessary
payments or adjustments arising through the Closing Date. The Company has not instituted any “freeze” of, or delayed or deferred the grant of, any cost-of-living or other salary adjustment for any Company Employee. The Company has not
engaged in any unfair labor practice or discriminated on the basis of race, color, religion, sex, national origin, age, disability or handicap in its employment conditions or practices. No employee or independent contractor has filed or, to the
Company’s Knowledge, overtly threatened any claims against the Company relating to employment or similar matters (including compensation and benefits). There are not in existence or, to the Company’s Knowledge, threatened any (y) work
stoppages respecting employees or independent contractors of the Company or (z) unfair labor practice 

  

 26. 

 
complaints against the Company. The Company is not a party to any collective bargaining Contract applicable to any Company Employees. No representation
question exists respecting the Company Employees and no collective bargaining Contract is currently being negotiated by the Company covering its employees, nor is any grievance procedure or arbitration proceeding pending under any collective
bargaining Contract and no claim therefor has been asserted. The Company has not received notice from any union or the Company Employees setting forth demands for representation, elections or for present or future changes in wages, terms of
employment or working conditions. There have been no audits of the equal employment opportunity practices of the Company. The Company has previously delivered or otherwise made available to Purchaser true and complete copies of the current written
personnel policies, manuals and/or handbooks of the Company and all service, employment, consulting, severance and termination Contracts with or for the benefit of, or otherwise relating to, any Company Employees or directors, officers, consultants
or independent contractors of the Company. Neither the Company nor, to the Knowledge of the Company, any director, officer, Company Employee, consultant or independent contractor is in default in any material respect under any service, employment,
consulting, severance or termination Contract relating to the Company. Except as set forth on Section 3.14(f) of the Company Disclosure Schedule or as required by Law, none of the execution, delivery or performance of this Agreement or the
Ancillary Agreements or the consummation of the transactions contemplated hereby and thereby, in and of themselves, will result in any obligation to pay any directors, officers, Company Employees, consultants, independent contractors, former
directors, officers, employees, consultants or independent contractors of the Company severance pay or termination, retention or other benefits or payments. No Company Employee or consultant or independent contractor of the Company has given written
notice to, or received written notice from, the Company or any of its representatives of an intention to resign or that any such person’s employment or service may otherwise be terminated. 
 Section 3.15 Contracts. The Company Disclosure Schedule lists each currently effective Contract to which the Company is a party or any of the
Assets are bound including (i) any employment, severance, consulting or other similar Contract with a Company Employee or consultant other than offer letters on the Company’s standard form (which has previously been provided to Purchaser)
that do not include any post-termination payments or benefits (including severance or acceleration of vesting following termination); (ii) any Contract of indemnification, guaranty, support or similar commitment; (iii) any Contract
containing any covenant limiting the freedom of the Company to engage in any line of business or to compete with any Person; (iv) any Contract relating to the disposition or acquisition of material assets or any material interest in any
business enterprise outside the ordinary course of business; (v) any Contract relating to currency exchange, commodities or other hedging arrangements or any leasing transaction of the type required to be capitalized in accordance with GAAP;
(vi) any Contract that contains restrictions with respect to payment of dividends or any other distribution; (vii) any joint venture, partnership agreement, limited liability company agreement and any other similar Contract (however named)
involving a sharing of profits or losses by the Company with any other Person and (viii) any Contract containing payment obligations or rights of the Company in excess of $10,000 (together, the “Company Contracts”). True
and correct copies of all of the Company Contracts have been furnished to the Purchaser. With respect to each Company Contract: (i) the agreement is legal, valid, binding, enforceable against the Company (and, to the Knowledge of the Company,
each other party thereto) and in full force and effect, subject to 

  

 27. 

 
(a) laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (b) rules of law governing specific performance,
injunctive relief and other equitable remedies; (ii) the agreement will continue to be legal, valid, binding, enforceable against the Company (and, to the Knowledge of the Company, each other party thereto) and in full force and effect on
identical terms immediately following the consummation of the transactions contemplated hereby, subject to (a) laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (b) rules of law governing
specific performance, injunctive relief and other equitable remedies; (iii) neither the Company nor, to the Company’s Knowledge, any other party thereto, is in breach or default in any material respect, and to the Company’s Knowledge,
no event has occurred which with notice or lapse of time would constitute a breach or default in any material respect, or permit termination, modification or acceleration, under the agreement; and (iv) neither the Company nor, to the
Company’s Knowledge, any other party thereto has repudiated any provision of the agreement. There are no material liabilities of the Company or, to the Company’s Knowledge, any other party to any of the Company Contracts arising from any
breach of or default in any provision thereof, nor has there occurred any material breach or default thereof by the Company which would permit the acceleration of any obligation of any party thereto or the creation of a Lien upon any of the Assets.
There are no negotiations pending or in progress to revise any material terms of such Company Contracts in a manner that would reasonably be expected to have a materially negative impact on the Company. 
 Section 3.16 Insurance Policies. The Company Disclosure Schedule (a) contains a true, correct and complete description of all insurance
agreements and policies maintained by the Company, and the type and amounts of coverage thereunder, and (b) reflects all such insurance required by Law. Such agreements and policies are in full force and effect, the Company is not delinquent
with respect to any premium payments thereon, and the Company has not received any notice of cancellation or termination with respect to any such policy. Since January 1, 2003, the Company has not been refused insurance coverage, nor has any
insurer otherwise reserved rights, nor has any claim in excess of $10,000 been made in respect of any such agreement or policy. The Company has not failed to give any notice or present any claim under any such insurance policy or agreement in due
and timely fashion. There are no pending claims against such insurance agreements and policies by or on behalf of the Company. All retroactive premium adjustments under any worker’s compensation policy of the Company have been recorded in the
Financial Statements in accordance with GAAP and are reflected in the Financial Statements. 
 Section 3.17 Records. The Company
has records that accurately and validly reflect its transactions and accounting controls sufficient to insure that such transactions are (i) in all material respects executed in accordance with its management’s general or specific
authorization and (ii) recorded in conformity with GAAP. 
 Section 3.18 Brokers. No broker, finder or investment banker is
entitled to any brokerage, finder’s or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company or its Affiliates. 
  

 28. 

 Section 3.19 Suppliers and Customers. 
 (a) The Company Disclosure Schedule lists (i) all suppliers of the Company to which the Company made payments during the fiscal year ended
December 31, 2007, or expects to make payments during the fiscal year ending December 31, 2008, in excess of $250,000 and (ii) all customers of the Company that paid the Company during the fiscal year ended December 31, 2007 or
that the Company expects will pay to the Company during the fiscal year ending December 31, 2008, more than $250,000. 
 (b) The
Company has no information which would reasonably indicate that any of its customers or suppliers listed on the Company Disclosure Schedule intends to cease purchasing from, selling to or dealing with the Company, nor has any information been
brought to the Company’s attention which would reasonably lead the Company to believe any such customer or supplier intends to alter in any material respect the amount of such purchases or sales or the extent of dealings with the Company or
would alter in any material respect such purchases, sales or dealings in the event of the consummation of the transactions contemplated by this Agreement. The Company has no information which would reasonably indicate, nor has any information been
brought to the Company’s attention which would reasonably lead the Company to believe that any customer of the Company will cancel outstanding or currently anticipated purchase orders placed by the Company which, individually or in the
aggregate, exceed $250,000. 
 (c) Neither the Company, nor, to the Knowledge of the Company, any of its officers, directors or
Affiliates, nor any immediate family member of any such officer, director or Affiliate, nor any entity controlled by one of more of the foregoing: 
 (i) owns, directly or indirectly, any interest in (excepting less than 2% stock holdings for investment purposes in securities of publicly held and traded companies), or is an officer, director, employee or consultant of, any Person
which is, or is engaged in business as, a competitor, lessor, lessee, supplier, distributor, sales agent, customer or client of the Company; 
 (ii) owns, directly or indirectly, in whole or in part, any Asset that the Company uses in the conduct of business; or 
 (iii) has, directly or indirectly, any cause of action or other claim whatsoever against, or owes any amount to, the Company, except for routine claims in the ordinary course of business for accrued vacation pay and accrued benefits
under employee benefit plans and agreements existing on the date hereof. 
 Section 3.20 Intellectual Property. 
 (a) Section 3.20(a) of the Company Disclosure Schedule sets forth a complete list of all Registered Intellectual Property. Each issued patent
listed in Section 3.20(a) is valid and enforceable. 
 (b) Section 3.20(b) of the Company Disclosure Schedule sets forth a
complete list of all Company Intellectual Property that is material to and necessary for conducting the business of the Company as it is currently being conducted. 
  

 29. 

 (c) Section 3.20(c) of the Company Disclosure Schedule sets forth a complete list of all
Contracts relating to material technology, know-how and processes which the Company is licensed or authorized to use by others or which the Company has licensed or authorized for use by others, or is necessary to the material conduct of the
Company’s business as presently conducted, other than (i) non-exclusive licenses to third-party software that is not incorporated into, or used in the development, manufacturing, testing, distribution, maintenance, or support of, any
Company products; (ii) third-party software generally available on standard terms for less than $10,000; and (iii) nondisclosure and confidentiality agreements entered into in the ordinary course of business. 
 (d) The Company (i) owns all rights, title, and interest in all Company Intellectual Property free and clear of any Lien, including ownership
of pending and accrued causes of action for patent, trademark, or copyright infringement, misappropriation, and unfair business practice relating to the Company Intellectual Property and has the sole and exclusive right to bring actions for
infringement and misappropriation of such Company Intellectual Property, and (ii) owns free and clear of any Lien or otherwise has the right to use all Intellectual Property material to and necessary for conducting the business of the Company
as it is currently conducted. The operation by the Company of its business does not infringe any Intellectual Property or other proprietary right of any other Person and there is no unauthorized use, disclosure, infringement or misappropriation of
any Intellectual Property owned by the Company. The Company is not in material breach of, or material default under, any term of any Contract relating to Intellectual Property and no other party to any such Contract is in material breach thereof or
material default thereunder. 
 (e) Each item of Registered Intellectual Property that is material to and necessary for conducting the
business of the Company as it has been conducted during the six month period before Closing is valid and subsisting to the extent that all necessary registration, maintenance or annuity, and renewal fees due in connection with such item of
Registered Intellectual Property prior to or during such six month period have been made; all necessary documents and certificates in connection with such Registered Intellectual Property required to have been filed prior to or during such six month
period have been filed with the relevant patent, copyright, trademark or other authorities in the United States or non-United States jurisdictions, as the case may be, for the purposes of maintaining such Registered Intellectual Property; and all
patent, trademark, service mark and copyright applications set forth on Section 3.20(a) to the Company Disclosure Schedule have been duly filed. Section 3.20(e) of the Company Disclosure Schedule sets forth a list of those fees required to
be paid within ninety (90) days of the date of this Agreement to maintain the Registered Intellectual Property. 
 (f) All
employees, agents, consultants, contractors, or other Persons who have contributed to or participated in the creation or development of any Company Intellectual Property, including Company Software: (i) made such contribution pursuant to and
within the scope of employment with the Company as an employee or otherwise as a party to a “work-for-hire” agreement under which the Company is deemed to be the owner and/or author, as applicable, of all right, title, and interest
therein; or (ii) have executed a written assignment or other agreement to assign in favor of the Company transferring to the Company all right, title and interest in such Company Intellectual Property. 
  

 30. 

 (g) Section 3.20(g) of the Company Disclosure Schedule contains a list of the Company
Software by name and version number that is currently being distributed or supported by the Company as a separate software product (“Company Product”). Except as set forth on Section 3.20(g) of the Company Disclosure
Schedule: (i) the Company has developed the Company Software through its own efforts and for its own account without the aid or use of any consultants, agents, independent contractors or Persons (other than Persons that are employees of the
Company or consultants and contractors that have assigned all rights in the Company Software to the Company); (ii) the Company owns the Company Software; (iii) no third party has any right to compensation from the Company by reason of, the
use, exploitation, or sale of the Company Software; (iv) none of the Company Software contains any source code or portions of source code (including any “third party software” or “free-ware”) created by any party other than
the authors of the Company Software on behalf of the Company or that has otherwise been assigned to the Company; (v) the Company Software is not subject by Contract to any transfer, assignment, site, equipment, or other operational limitation;
(vi) the Company has maintained and protected the Company Software that is a Company Product with appropriate proprietary notices (including, without limitation, the notice of copyright in accordance with the requirements of 17 U.S.C. §
401), confidentiality and non-disclosure agreements and such other measures as are reasonably necessary to protect the proprietary, trade secret or confidential information contained therein; (vii) the Company Software has been registered or
may be eligible for protection and registration under applicable U.S. copyright law and has not been forfeited to the public domain; (viii) the Company has copies of all current releases or separate versions of the Company Software that is a
Company Product; (ix) to the Company’s Knowledge, the Company Software does not infringe any copyright or other Intellectual Property rights of any other Person; (x) to the extent used in the business of the Company as it has been
conducted during the six month period before Closing, for the Company Software that is a Company Product, the Company has the source code, system documentation, statements of principles of operation, as well as any pertinent release notes,
explanation, compilers, workbenches, tools, and documentation regarding ongoing development used for the development, maintenance, implementation and use thereof, so that a computer programmer reasonably skilled in the applicable area could develop,
maintain, support, compile and use all releases or separate versions of the same that are currently subject to maintenance obligations by the Company; (xi) there are no Contracts in effect with respect to the marketing, distribution, licensing
or promotion of the Company Software by any other Person; (xii) the Company does not have any source code for the Company Software or other Company Intellectual Property held in escrow; and (xiii) the Company has not received any notice
of, and the Company has no Knowledge of, any complaint, assertion, threat, or allegation that the Company Software infringes the rights of any third party. 
 (h) The Company does not use any Intellectual Property it does not own or have a license to use, including “off-the-shelf” software, and all licenses for “off the shelf” software used by the
Company are fully paid or are paid for on an annual basis. Section 3.20(h) of the Company Disclosure Schedule sets forth a complete and accurate list of all license agreements granting to the Company any material right to use or practice any
rights under any Intellectual Property other than commercially available “off-the-shelf” software and other than rights to use trade secrets or confidential information under confidentiality or nondisclosure agreements (collectively, the
“Inbound License Agreements”), indicating for each the title and the parties thereto and the amount of any future royalty or license fee payable thereunder for which the Company is contractually obligated to pay as of the
date of this Agreement. 
  

 31. 

 (i) Section 3.20(i) of the Company Disclosure Schedule sets forth a complete and accurate
list of all license agreements under which the Company licenses software or grants other rights in or to use or practice any rights under any Intellectual Property (collectively, the “Outbound License Agreements”), indicating
for each the title and the parties thereto. As of the date of this Agreement, there is no material outstanding or overtly threatened dispute or disagreement with respect to any Inbound License Agreement or any Outbound License Agreement. 

(j) Since April 1, 2005, until the date of this Agreement, no claims of any kind have been made by the Company against any third party
that, and Company has no Knowledge that, any third party infringes, or has previously infringed, misappropriates, or has previously misappropriated, any Company Intellectual Property. 
 (k) No claims of any kind have been made or asserted, or threatened, by any party against the Company claiming or alleging that the Company or any
of its products (including products currently under development), services, or methods of operation infringe, have infringed, or misappropriate the Intellectual Property of any third party, or constitute unfair competition. 
 (l) With respect to the Company’s trade secrets, know-how, proprietary processes, confidential business information, formulae, algorithms,
models, user interfaces, inventions, discoveries, concepts, ideas, techniques, methods, source codes, object codes, methodologies, whether patentable or unpatentable and whether or not reduced to practice, manufacturing and production processes and
techniques, research and development information, copyrightable works, financial, marketing and business data, pricing and cost information, business and marketing plans, customer and supplier lists and information and all other proprietary rights
relating to any of the foregoing, the Company has taken reasonable steps in accordance with normal industry practice to protect its respective rights in such confidential information and trade secrets that the Company elects to keep confidential;
all Company Employees and independent contractors of the Company are under written obligation to the Company to maintain in confidence all confidential or proprietary information acquired by them in the course of their employment or Contract and to
assign to the Company all inventions and know-how made by them within the scope of their employment or Contract; and, except under confidentiality obligations, there has been no disclosure by the Company of material confidential information or trade
secrets that the Company elects to keep confidential. 
 (m) The execution, delivery and performance by the Company of this Agreement,
and the consummation of the transactions contemplated hereby, will not result in the loss or impairment of, or give rise to any right of any third party to terminate or alter, any of the Company’s rights to own any of its Intellectual Property
or their respective rights under any Inbound License Agreement or any Outbound License Agreement, nor require the consent of any Governmental Authority or third party in respect of any such Intellectual Property. 
  

 32. 

 (n) In connection with any collection of personally identifiable information, the Company has
complied in all material respects with all Laws and its publicly available privacy policy (if any) relating to the collection, storage and onward transfer of all personally identifiable information collected by the Company. 
 Section 3.21 Licenses. The Company holds all Licenses necessary for the operation of its business as currently operated, all of which
Licenses are set forth on the Company Disclosure Schedule. All of such Licenses are in full force and effect in all material respects, the Company is in compliance in all material respects with the terms of such Licenses, and no Action is pending
nor, to the Knowledge of the Company, is overtly threatened to revoke or terminate any License or declare any License invalid in any material respect. The Company has taken all necessary action to maintain such Licenses. 
 Section 3.22 No Illegal or Improper Transactions. Neither the Company nor, to the Company’s Knowledge, any director, officer or employee
of the Company has, directly or indirectly, used funds or other Assets of the Company, or made any promise or undertaking in such regards, for (a) illegal contributions, gifts, entertainment or other expenses relating to political activity,
(b) illegal payments to or for the benefit of governmental officials or employees, whether domestic or foreign, (c) illegal payments to or for the benefit of any Person, or any director, officer, employee, agent or representative thereof,
or (d) the establishment or maintenance of a secret or unrecorded fund, and there have been no false or fictitious entries made in the books or records of the Company. 
 ARTICLE IV 
 REPRESENTATIONS AND
WARRANTIES OF THE PURCHASER AND MERGER SUB 
 The Purchaser and Merger Sub represent and warrant to the Company that the statements contained in this Article IV are true, correct and complete as of the date of this Agreement and will be true, correct and complete
as of the Closing Date (as though made then and as though the Closing Date were substituted for the date of this Agreement throughout this Article IV), except as set forth in the Purchaser Disclosure Schedule. Nothing in the Purchaser Disclosure
Schedule shall be deemed adequate to disclose an exception to a representation or warranty made herein, however, unless the Purchaser Disclosure Schedule identifies the exception with reasonable particularity and describes the relevant facts in
reasonable detail. The Purchaser Disclosure Schedule will be arranged in paragraphs corresponding to the lettered and numbered paragraphs contained in this Article IV; provided, however, that any information disclosed therein under any
section number shall be deemed to be disclosed and incorporated in any other section of the Purchaser Disclosure Schedule where such disclosure would be appropriate and reasonably apparent from the description in the Purchaser Disclosure Schedule of
any information or document in the Purchaser Disclosure Schedule shall not be deemed a statement or admission that it is material or required to be disclosed therein. 
 Section 4.01 Purchaser Organization, Etc. The Purchaser is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. Merger Sub is a corporation duly
organized, validly existing and in good standing under the laws of the State of California. Each of the Purchaser and Merger Sub is duly qualified or licensed to do 

  

 33. 

 
business, and is in good standing, as a foreign corporation in each jurisdiction where the character of its business or the nature of its properties makes
such qualification or licensing necessary, except where the failure to so qualify or be licensed would not have a Purchaser Material Adverse Effect. Merger Sub has been organized solely for the purpose of consummating the transactions contemplated
hereby and does not, and has never, conducted any business or other operations. The Purchaser has full power and authority to conduct its business as it is now being conducted and to own, operate or lease the properties and assets it currently owns,
operates or holds under lease. Each of the Purchaser and Merger Sub has heretofore made available to the Company true and correct copies of its organizational documents as in effect on the date hereof. Each of the Purchaser and Merger Sub has all
requisite power and authority to enter into this Agreement and each of the Ancillary Agreements to which it is a party, to carry out its obligations under this Agreement and each of the Ancillary Agreements to which it is a party, and to consummate
the transactions contemplated hereby and thereby. 
 Section 4.02 Capitalization. The authorized, issued and outstanding shares
of Purchaser Capital Stock, and any options, warrants or other direct or indirect rights to acquire shares of Purchaser Capital Stock are as set forth in Section 4.02 of the Purchaser Disclosure Schedule and are held of record (and, to the
Knowledge of Purchaser, beneficially) by the Persons and in the amounts and classes or series of shares as set forth in Section 4.02 of the Purchaser Disclosure Schedule. All outstanding shares of Purchaser Capital Stock are, and all shares
reserved for issuance will be, upon issuance in accordance with the terms specified in the instruments or Contracts pursuant to which they are issuable, duly authorized, validly issued, fully paid and non-assessable. None of the outstanding shares
of Purchaser Capital Stock are subject to preemptive rights created by statute, the Purchaser’s certificate of incorporation or any Contract to which the Purchaser is a party or by which it is bound. None of the outstanding shares of Purchaser
Capital Stock has been issued in violation of any preemptive rights, rights of first refusal or similar rights. Except as set forth in Section 4.02 of the Purchaser Disclosure Schedule (which sets forth the number of shares and class or series
of Purchaser Capital Stock issuable upon the exercise thereof and the exercise price thereof) and as contemplated by this Agreement, there are no outstanding options, warrants, convertible securities, calls, rights, commitments, preemptive rights or
agreements or instruments or understandings of any character to which the Purchaser is a party or by which the Purchaser is bound, obligating the Purchaser to issue, deliver or sell, or cause to be issued, delivered or sold, contingently or
otherwise, additional capital stock or any securities or obligations convertible into or exchangeable for such capital stock or to grant, extend or enter into any such option, warrant, convertible security, call, right, commitment, preemptive right
or agreement. There are no voting trust agreements or other Contracts or understandings restricting or otherwise relating to voting, dividend or other rights with respect to the capital stock of the Purchaser. The Purchaser does not have any
Subsidiaries and does not own, directly or indirectly, any capital stock or other equity interest in any corporation, partnership, joint venture or other entity. 
 Section 4.03 Authorization. The execution and delivery by each of the Purchaser and Merger Sub of this Agreement and the Ancillary Agreements to which it is a party, the performance by each of the
Purchaser and Merger Sub of its obligations hereunder and thereunder and the consummation by each of the Purchaser and Merger Sub of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the
part of the Purchaser and Merger Sub. This Agreement has been, and each Ancillary 

  

 34. 

 
Agreement to which the Purchaser or Merger Sub is a party will be, duly executed and delivered by the Purchaser or Merger Sub, as applicable, and (assuming
due authorization, execution, and delivery by the other parties thereto) this Agreement is, and each Ancillary Agreement to which the Purchaser or Merger Sub is a party will be, when duly executed and delivered, a legal, valid and binding obligation
of the Purchaser or Merger Sub, as applicable, enforceable against the Purchaser or Merger Sub, as applicable, in accordance with its terms (except as the enforceability thereof may be limited by any applicable bankruptcy, insolvency or other Laws
affecting creditors’ rights generally or by general principles of equity, regardless of whether such enforceability is considered in equity or at law). 
 Section 4.04 No Violation. The execution, delivery and performance of this Agreement and the Ancillary Agreements do not and will not (a) violate or conflict with the certificate of incorporation or
by-laws of the Purchaser, Merger Sub or any other Subsidiary of the Purchaser, (b) conflict with or violate any Law or Governmental Order applicable to the Purchaser, Merger Sub or any other Subsidiary of the Purchaser, or (c) result in
any breach of, or constitute a default (or event which with the giving of notice or lapse of time, or both, would become a default) under, or give to any Person any rights of termination, amendment, acceleration or cancellation of, or give to any
Person any additional rights or entitlement to increased, additional, accelerated or guaranteed payments under, or result in the creation of any Lien on any of the assets or properties of the Purchaser, Merger Sub or any other Subsidiary of the
Purchaser pursuant to, any Contract, License or other instrument to which the Purchaser, Merger Sub or any other Subsidiary of the Purchaser is a party or by which any of the assets or properties of the Purchaser, Merger Sub or any other Subsidiary
of the Purchaser are bound or affected, except for such violations, conflicts, breaches or defaults as would not have a Purchaser Material Adverse Effect. 
 Section 4.05 Approvals. The execution and delivery of this Agreement and the Ancillary Agreements by the Purchaser and Merger Sub do not, and the performance of this Agreement and the Ancillary Agreements
by the Purchaser and Merger Sub will not, require any consent, approval, authorization or other action by, or filing with or notification to, any Governmental Authority or other Person under any Law or Contract, other than the filing of the
Certificate of Merger and such filings or registrations with, or authorizations, consents or approvals of Governmental Authorities the failure of which to make or obtain would not have a Purchaser Material Adverse Effect. 
 Section 4.06 Financial Statements and Other Information. 
 (a) True, correct and complete copies of the Purchaser’s unaudited consolidated balance sheets as of December 31, 2005, 2006 and 2007 and the related unaudited consolidated statements of operations
and cash flows for the years then ended (collectively, the “Purchaser Financial Statements”) are set forth in Section 4.06 of the Purchaser Disclosure Schedule. The unaudited consolidated balance sheet of the Purchaser
as of December 31, 2007 is referred to as the “Purchaser Balance Sheet”. 
 (b) The Purchaser Financial
Statements are in accordance with the books and records of the Purchaser and its Subsidiaries and have been prepared in accordance with GAAP consistently applied throughout the periods covered thereby and the balance sheets included 

  

 35. 

 
therein present fairly as of their respective dates the consolidated financial condition of the Purchaser. All liabilities and obligations, whether absolute,
accrued, contingent or otherwise, whether direct or indirect, and whether due or to become due, which existed at the date of the Purchaser Balance Sheet have been disclosed in the Purchaser Balance Sheet to the extent such liabilities were required,
under GAAP, to be so disclosed. The statements of operations and cash flows included in the Purchaser Financial Statements present fairly the consolidated results of operations and cash flows of the Purchaser for the periods indicated. 

(c) Except as set forth in the Purchaser Disclosure Schedule, the liabilities on the Purchaser Balance Sheet consist solely of accrued
obligations and liabilities incurred by the Purchaser in the ordinary course of business to Persons which are not Affiliates of the Purchaser. There are no liabilities of the Purchaser of any kind whatsoever, whether or not accrued and whether or
not contingent or absolute, determined or determinable or otherwise, including, without limitation, documentary or standby letters of credit, bid or performance bonds, or customer or third party guarantees, and no existing condition, situation or
set of circumstances that could reasonably result in such a liability, other than (i) liabilities disclosed in the Purchaser Financial Statements, and (ii) liabilities which have arisen after the date of the Purchaser Balance Sheet in the
ordinary course of business and consistent with past practice (none of which is a liability for breach of contract, breach of warranty, tort, infringement claim or lawsuit) which liabilities, individually or in the aggregate, are not material.

 Section 4.07 Absence of Certain Changes or Events. Since December 31, 2007, there has been no Purchaser Material Adverse
Effect. 
 Section 4.08 Litigation. There are no Actions pending or, to the Knowledge of the Purchaser, overtly threatened
against the Purchaser or any of its Subsidiaries or their respective assets which would be reasonably likely to have a Purchaser Material Adverse Effect. 
 Section 4.09 Issuance. The shares of Purchaser Common Stock to be issued by the Purchaser hereunder have been duly authorized and, when issued and delivered in accordance with the terms of this Agreement,
will be validly issued, fully paid and non-assessable and will not be issued in violation of any preemptive rights, rights of first refusal or similar rights. 
 Section 4.10 Taxes. Neither Purchaser nor Merger Sub has taken or agreed to take any action, has failed to take any action or knows of any fact, Contract, plan or other circumstance that is reasonably
likely to prevent the Merger from qualifying as a reorganization within the meaning of Section 368(a) of the Code. 
 Section 4.11 Intellectual Property. Since December 1, 2005, neither the Purchaser nor any of its Subsidiaries has received any communication relating to any actual, alleged, or suspected infringement, misappropriation, or
violation by the Purchaser or any of its Subsidiaries of any Intellectual Property of another Person. Since December 1, 2005, neither the Purchaser nor any of its Subsidiaries has received any communication relating to any request to license
any Intellectual Property of another Person. 
  

 36. 

 ARTICLE IVA 
 REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDER REPRESENTATIVE 
 The Shareholder Representative represents and warrants to the Company, the Purchaser and Merger Sub that the statements contained in this Article IVA are
true, correct and complete as of the date of this Agreement and will be true, correct and complete as of the Closing Date (as though made then and as though the Closing Date were substituted for the date of this Agreement throughout this Article
IVA) 
 Section 4A.01 Organization, Etc. The Shareholder Representative is a limited liability company duly organized, validly
existing and in good standing under the laws of the State of Colorado. 
 Section 4A.02 Authorization. The execution and delivery
by the Shareholder Representative of this Agreement and the Ancillary Agreements to which it is a party, the performance by it of its obligations hereunder and thereunder and the consummation by it of the transactions contemplated hereby and thereby
have been duly authorized by all necessary limited liability company action on the part of the Shareholder Representative. This Agreement has been, and each Ancillary Agreement to which the Shareholder Representative is a party will be, duly
executed and delivered by the Shareholder Representative, and (assuming due authorization, execution, and delivery by the other parties thereto) this Agreement is, and each Ancillary Agreement to which the Shareholder Representative is a party will
be, when duly executed and delivered, a legal, valid and binding obligation of the Shareholder Representative, enforceable against the Shareholder Representative in accordance with its terms (except as the enforceability thereof may be limited by
any public policy or Law limiting the power or scope of authority of representatives of equity holders generally, including, without limitation, as a result of any lack of privity of contract or any unlawful assignment of shareholder rights, any
applicable bankruptcy, insolvency or other Laws affecting creditors’ rights generally or by general principles of equity, regardless of whether such enforceability is considered in equity or at law). 
 Section 4A.03 No Violation. The execution, delivery and performance of this Agreement and the Ancillary Agreements do not and will not
(a) violate or conflict with the certificate of formation and limited liability company agreement or other organizational and governing documents of the Shareholder Representative or (b) conflict with or violate any Contract or
Governmental Order applicable to the Shareholder Representative. 
 ARTICLE V 
 COVENANTS 
 Section 5.01 General. Each of the parties
will use its commercially reasonable efforts to take all actions and to do all things necessary, proper, or advisable in order to consummate and make effective the transactions contemplated by this Agreement (including obtaining the Shareholder
Approval and satisfaction, but not waiver, of the closing conditions set forth in Articles VII and VIII below). 
  

 37. 

 Section 5.02 Access to Premises and Information. From the date hereof until the Effective
Time or the earlier termination of this Agreement, the Company and Purchaser shall each (a) give the other party, its counsel, financial advisors, auditors and other authorized representatives reasonable access to the offices, properties, books
and records of such party, (b) furnish to the other party, its counsel, financial advisors, auditors and other authorized representatives such financial and operating data and other information relating to such party as such Persons may
reasonably request and (c) instruct its employees, counsel, financial advisors, auditors and other authorized representatives to cooperate with the other party in its investigation of such party. Any investigation pursuant to this Section shall
be conducted upon reasonable prior notice to the other party, during regular business hours and in such a manner so as not to interfere unreasonably with the conduct of the business of the other party. 
 Section 5.03 Conduct of Business in Ordinary Course. 
 (a) The Company will conduct its business diligently, in the ordinary course and in substantially the same manner as it was previously conducted, and will not make or institute any unusual or novel purchase,
sale, lease, change in management, accounting policy or operation that will vary materially from those methods used by it during the 12-month period ending on the date of this Agreement. Without limiting the foregoing, from the date hereof until the
Closing Date, the Company will: (i) not amend its articles of incorporation (except pursuant to the Amendment) or by-laws, (ii) not acquire or agree to acquire (A) by merging or consolidating with, or by purchasing a substantial
portion of the assets of, or by any other manner, any Person or (B) any material assets, except purchases in the ordinary course of business, (iii) not change the compensation of any of its officers, nor, except in the ordinary course of
business consistent with past practice, increase any compensation (including, without limitation, any bonuses) payable to any Company Employee or consultant of the Company, not enter into any employment, severance or other Contract with any of its
officers or any Company Employee or consultants and not enter into, amend or adopt any Employee Plan (provided that the Company may, prior to Closing and pursuant to documentation reasonably satisfactory to Purchaser, amend the terms of its
1999 Incentive Stock Plan, as amended, or any Company Option granted thereunder, to provide that (i) all outstanding Employee Options will vest in full on the one-year anniversary of the Closing Date and (ii) all holders of outstanding
Director Options will be entitled to early exercise such Director Options), (iv) not enter into, amend or terminate any material Contract without the prior written consent of the Purchaser, except in the ordinary course of business,
(v) not enter into any commitment to borrow money or subject to Lien any of the Assets, (vi) not sell or transfer any of the Assets or cancel any claim except in the ordinary course of business, (vii) not dispose of any shares of
capital stock (or securities exchangeable for its shares of capital stock), or declare or pay any dividend or make any distribution in respect of any shares of capital stock of the Company or enter into any Contract with respect thereto except in
accordance with the terms of this Agreement or as mutually agreed by the Purchaser and the Company, (viii) perform all material obligations under Licenses, the Company Contracts and other documents relating to or affecting the Company, all in
the same manner as heretofore performed, (ix) use its commercially reasonable efforts to maintain and preserve the business of the Company, the goodwill and relationships with the Company Employees, customers, suppliers and others having a
business relationship with the Company, and maintain all Licenses requisite to the conduct of its business as now conducted, (x) maintain in working condition all equipment and other personal property that are Assets, reasonable wear 

  

 38. 

 
and tear excepted, (xi) comply with all Laws and Governmental Orders, (xii) not enter into any license, technology development or technology
transfer agreement with any person or entity (other than the Purchaser) which would reasonably be expected to have a Company Material Adverse Effect, (xiii) not enter into negotiations with, or solicit offers from, any party, directly or
indirectly, for the sale of all or substantially all of the Assets, (xiv) not, without the prior written consent of the Purchaser, directly or indirectly (1) change or make any election in respect of Taxes, (2) change or adopt any
annual Tax accounting period or method of Tax accounting in any material respect, (3) file any amendment to a Tax Return, (4) enter into any closing agreement relating to any Tax, (5) settle or compromise any claim or assessment in
respect of Taxes that would materially affect the Company or its income, operations, assets or activities, (6) surrender any right to claim a Tax refund or (7) consent to any extension or waiver of the limitations period applicable to any
claim or assessment in respect of Taxes and (xv) not take any action or omit to take any action which act or omission would result in the inaccuracy of any of its representations and warranties set forth herein if such representations or
warranties were to be made immediately after the occurrence of such act or omission. 
 Section 5.04 Updating of Disclosure
Schedules. The Company undertakes to revise and update the Company Disclosure Schedule and the Purchaser undertakes to revise and update the Purchaser Disclosure Schedule as may be necessary from the date hereof until the Closing Date. No such
update provided or revisions made to the Company Disclosure Schedule pursuant to this Section shall be deemed to be accepted by the Purchaser, nor cure any breach of any representation or warranty made in this Agreement, unless the Purchaser
specifically agrees thereto in writing, nor shall any such update or revision thereto be considered to constitute or give rise to a waiver by the Purchaser of any condition set forth in this Agreement. No such update provided or revisions made to
the Purchaser Disclosure Schedule pursuant to this Section shall be deemed to be accepted by the Company, nor cure any breach of any representation or warranty made in this Agreement, unless the Company specifically agrees thereto in writing, nor
shall any such update or revision thereto be considered to constitute or give rise to a waiver by the Company of any condition set forth in this Agreement. 
 Section 5.05 Further Assurances. In case at any time after the Closing any further action is necessary or desirable to carry out the purposes of this Agreement, each of the parties will cooperate with the
other and take such further action (including the execution and delivery of such further instruments and documents) as any other party reasonably may request. 
 Section 5.06 No Shopping. 
 (a) From and after the date hereof until the termination of
this Agreement, without the express written consent of the Purchaser, the Company shall not, and shall cause its officers, directors, employees and representatives not to, directly or indirectly, (i) solicit or initiate discussions with any
Person, other than the Purchaser, relating to the possible acquisition of the Company or any material part of the Assets, whether by way of merger, reorganization, purchase of shares of capital stock, purchase of Assets, management agreement,
license agreement with respect to the Assets, or otherwise (any such acquisition or other transaction or agreement being referred to herein as an “Acquisition Transaction”), (ii) except as required in order for the board
of directors of the Company to fulfill its fiduciary duties to the stockholders of the Company as reasonably determined by the board of directors of the Company in good faith 

  

 39. 

 
after consultation with outside counsel, engage in negotiations with or provide information with respect to the Assets to any Person, other than the
Purchaser, in connection with a possible Acquisition Transaction or (iii) except as required in order for the board of directors of the Company to fulfill its fiduciary duties to the stockholders of the Company as reasonably determined by the
board of directors of the Company in good faith after consultation with outside counsel, enter into a transaction with any Person, other than the Purchaser, concerning a possible Acquisition Transaction. If after the date of this Agreement the
Company receives an unsolicited offer or proposal relating to a possible Acquisition Transaction, the Company shall, within one Business Day, notify the Purchaser and provide information to the Purchaser as to the identity of the party making any
such offer or proposal and the specific terms of such offer or proposal (including, without limitation, the proposed price and financing therefor). 
 (b) In the event that (i) the board of directors (or any committee thereof) of the Company (x) withdraws or modifies (in a manner adverse to Purchaser) its recommendation to the Company’s shareholders referred to
Section 6.02 hereof or takes any action not explicitly permitted by this Agreement that would be inconsistent with its approval of the Merger, (y) causes or permits the Company to enter into (or publicly propose that the Company enter
into) any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement or similar agreement with respect to any Acquisition Transaction or (z) approves or recommends or proposes to approve or recommend any
Acquisition Transaction or any agreement, understanding or arrangement relating to any Acquisition Transaction (or resolves or authorizes or proposes to agree to do any of the foregoing actions) or (ii) the Company holds a meeting of its
shareholders pursuant to Section 6.02 hereof and the Shareholder Approval is not obtained, then, in addition to any other remedy the Purchaser may be entitled to at Law or in equity, including specific performance, the Company shall immediately
pay the Purchaser, as a negotiated fee and not liquidated damages, the amount of $800,000 plus all of Purchaser’s out-of pocket expenses incurred in connection with the transactions contemplated by this Agreement. 
 (c) The Company hereby recognizes and acknowledges that a breach of its obligations under this Section 5.06 will cause irreparable and
material loss and damage to the Purchaser as to which the Purchaser will not have an adequate remedy at Law or in damages. Accordingly, the Company acknowledges and agrees that the issuance of an injunction or other equitable remedy is an
appropriate remedy for any such breach. 
 Section 5.07 Consents. The Company and the Purchaser, as promptly as practicable
(a) will make, or cause to be made, all filings and submissions under Law applicable to it, or to its Subsidiaries and Affiliates, as may be required for any party hereto to consummate the transactions contemplated hereby, (b) will use
their respective commercially reasonable efforts to obtain, or cause to be obtained, all authorizations, approvals, consents and waivers from all Persons and Governmental Authorities necessary to be obtained by either of them in order to consummate
such transactions, and (c) will use their respective commercially reasonable efforts to take, or cause to be taken, all other actions necessary, proper or advisable in order for each of them to fulfill their respective obligations hereunder.
The Company and the Purchaser will coordinate and cooperate with one another in exchanging information and supplying such reasonable assistance as may be reasonably requested by each in connection with the foregoing. 
  

 40. 

 Section 5.08 Public Announcements. Unless and to the extent required by Law, each party
hereto will agree in advance prior to the issuance by either of them of any press release or the making of any public statement with respect to this Agreement and the transactions contemplated hereby and shall not issue any such press release or
make any such public statement without the agreement of the other party. In the event that any party is required to issue a press release or make a public statement by Law, it will use its commercially reasonable efforts to notify the other party of
the contents thereof in advance of the issuance or making thereof. 
 Section 5.09 Confidentiality Obligations of the Parties.
Each party will hold, and will cause its officers, directors, employees, accountants, counsel, consultants, advisors and agents to hold, in confidence all documents and information concerning the other party obtained from the other party either
before or after the date of this Agreement in accordance with the terms of that certain Confidentiality Agreement, dated as of July 11, 2006, as amended, between the Purchaser and the Company. 
 Section 5.10 Updated Financial Statements. As soon as available and in any event within forty-five (45) days after the end of each month
prior to the Closing Date, commencing with January 31, 2008, each of the Company and the Purchaser shall deliver to the other an unaudited consolidated balance sheet and related unaudited consolidated statements of income and cash flows of such
party as of and for the month then ended. All such financial statements of the Company shall be covered by and conform to the representations and warranties applicable to the Company Financial Statements set forth in Section 2.07 and shall be
included in the term “Company Financial Statements” for purposes of this Agreement, and all such financial statements of the Purchaser shall be covered by and conform to the representations and warranties applicable to the Purchaser
Financial Statements set forth in Section 4.05 and shall be included in the term “Purchaser Financial Statements” for purposes of this Agreement. 
 Section 5.11 Employee Matters. 
 (a) Immediately after the Effective Time, the Purchaser
shall provide or cause the Surviving Corporation to provide the Continuing Employees with the same employee benefits they had immediately prior to the Effective Time. The Purchaser will either (i) maintain the Company’s existing welfare
benefit and flexible benefit plans on substantially the same terms as are in effect on the date hereof through December 31, 2008 or (ii) provide the Continuing Employees with employee benefits on substantially the same terms and conditions
as those provided to Purchaser’s similarly situated employees, in which case (A) the Continuing Employees will be credited with their service with the Company for purposes of eligibility and vesting (but not benefit accrual) under the
employee benefit plans or programs of Purchaser and the Surviving Corporation in which they are eligible to participate if and to the extent such service was credited to such Continuing Employees under the Company’s corresponding employee
benefit plans and programs and (B) the Continuing Employees will be credited with their out of pocket expenses or deductible amounts under analogous Company benefit plans (provided adequate proof and documentation of such expenses and amounts
are provided) and their flexible spending plan elections (and carry over any unused flexible spending account balances) will be honored, with respect to the plan year in which the Effective Time occurs. 
  

 41. 

 (b) No term of this Agreement shall be deemed to create any contract between the Purchaser and any
current employee of the Company which gives the employee the right to be retained in the employment of the Purchaser, the Company or any related employer, or to interfere with the Company’s right to terminate employment of any employee at any
time or to change its policies regarding salaries, benefits and other employment matters at any time or from time to time. 
 (c) The
representations, warranties, covenants and agreements contained herein are for the sole benefit of the parties hereto, and employees are not intended to be and shall not be construed as beneficiaries hereof. No provision of this Agreement shall
create any third party beneficiary or other rights in any employee or former employee (including any beneficiary or dependent thereof) of the Company in respect of employment with the Purchaser in respect of any benefits that may be provided,
directly or indirectly, under any employee benefit plan, agreement, policy or arrangement which may be established by the Purchaser. No provision of this Agreement shall constitute a limitation on rights to amend, modify or terminate after the
Closing Date any such plans, agreements, policies or arrangements of the Purchaser. 
 Section 5.12 Certain Tax Matters.

 (a) Transfer Taxes. The Shareholder Representative shall authorize timely payment from the Escrow Fund of all Transfer Taxes,
and the Purchaser will, at its expense, file all necessary Tax Returns and other documentation required to be filed with respect to all Transfer Taxes. 
 (b) Tax Returns. Purchaser shall prepare (or cause to be prepared) and file (or cause to be filed) all Tax Returns of the Company required to be filed after the Closing Date. 
 (c) Tax Audits. Purchaser shall control any and all Tax Contests. All costs, fees and expenses paid to third parties in the course of any Tax
Contest relating to any Pre-Closing Period or any Pre-Closing Partial Period shall be borne by the Purchaser and the Company in the same ratio as the ratio in which, pursuant to the terms of this Agreement, they would share the responsibility for
payment of the Taxes asserted by the Governmental Authority in such claim or assessment if such claim or assessment were sustained in its entirety. 
 (d) Straddle Periods. In the case of Taxes (other than Transfer Taxes) that are payable with respect to any Straddle Period, the portion of any such Tax that is attributable to a Pre-Closing Partial Period shall be: 
 (i) in the case of income Taxes or any other Taxes resulting from, or imposed on, sales, receipts, uses, transfers or assignments of property or
other assets, payments or accruals to other Persons (including, without limitation, wages), or any other similar transaction or transactions, the amount that would be payable for the Pre-Closing Partial Period if the Company filed a separate Tax
Return with respect to such Taxes solely for the Pre-Closing Partial Period; and 
 (ii) in the case of all other Taxes, an amount
equal to the amount of Taxes for the entire Straddle Period multiplied by a fraction the numerator of which is the number of calendar days in the Pre-Closing Partial Period and the denominator of which is the number of calendar days in the
entire Straddle Period. 
  

 42. 

 (e) Purchaser and the Company shall use commercially reasonable efforts to cause the Merger to
qualify as a “reorganization” within the meaning of Section 368(a) of the Code. This Agreement is intended to constitute a “plan of reorganization” within the meaning of Treasury Regulations Section 1.368-2(g).
Purchaser and the Company shall report the Merger as a reorganization in compliance with Treasury Regulations Section 1.368-3. 
 Section 5.13 Financial Statement Audit. Promptly following the date hereof, the Company will engage an audit firm approved by Purchaser to conduct an audit of the Company’s financial statements and, if requested by
Purchaser, assist with filing such financial statements with the Securities and Exchange Commission. The Company and its employees, counsel and other authorized representatives will fully cooperate with such firm. 
 ARTICLE VI 
 ADDITIONAL AGREEMENTS 
 Section 6.01 Proxy Statement and Shareholder Meeting. 

 (a) Proxy Statement. As soon as reasonably practicable after the date hereof the Company shall prepare, with the cooperation of
Purchaser, a proxy statement for stockholder solicitation of approval and adoption of this Agreement and the transactions contemplated hereby (the “Proxy Statement”). Each of the Company and Purchaser shall use its
commercially reasonable efforts to cause the Proxy Statement to comply with all requirements of applicable federal and state securities laws. Each of the Company and Purchaser shall provide promptly to the other such information concerning its
business and financial statements and affairs as may reasonably be required or appropriate for inclusion in the Proxy Statement or in any amendments or supplements thereto and to cause its counsel and auditors to cooperate with the other’s
counsel and auditors in the preparation of the Proxy Statement. Whenever any event occurs that is required to be set forth in an amendment or supplement to the Proxy Statement, the Company and Purchaser shall cooperate in delivering any such
amendment or supplement to the holders of Company Capital Stock, Company Options and/or Company Warrants. The Proxy Statement shall include the unanimous and unqualified recommendation of the board of directors of the Company in favor of adoption of
this Agreement and approval of the Merger and the conclusion of the board of directors of the Company that the terms and conditions of this Agreement and the Merger are fair, reasonable, advisable and in the best interests of the Company and its
securityholders. The Company shall not include in the Proxy Statement any information with respect to Purchaser or its Affiliates, the form and content of which has not been approved by Purchaser. 
 (b) Amendments and Supplements. Each of the Company and Purchaser shall use its commercially reasonable efforts to cause the information relating
to the Company and Purchaser included in the Proxy Statement not to, at the time such document is delivered to the holders of Company Capital Stock, Company Options and/or Company Warrants and at all times subsequent thereto, through and including
the Effective Time, contain any untrue statement 

  

 43. 

 
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The Company shall promptly advise Purchaser, and Purchaser shall promptly advise the Company, in writing if at any time prior to the Effective Time either the Company or Purchaser shall
obtain knowledge of any facts that might make it necessary or appropriate to amend or supplement the Proxy Statement in order to make the statements contained or incorporated by reference therein not misleading or to comply with applicable law. The
Company and Purchaser shall cooperate in delivering any such amendment or supplement to the holders of Company Capital Stock, Company Options and/or Company Warrants. The Company shall not distribute the Proxy Statement, or any amendment or
supplement thereto, to which the Purchaser reasonably objects, and the Company shall not and shall cause its representatives not to have any written, oral or other communication with the Holders which is in any way inconsistent with the Proxy
Statement, or any amendment or supplement thereto. The Company shall, and shall cause its representatives to, use commercially reasonable efforts to obtain the requisite approval of all classes of Company Capital Stock, Company Options and/or
Company Warrants to the adoption of this Agreement. 
 Section 6.02 Shareholder Meeting. As soon as reasonably practicable after
the date hereof, the Company shall deliver by personal delivery or reputable overnight courier the Proxy Statement to all holders of Company Capital Stock, Company Options and/or Company Warrants entitled to vote on the approval and adoption of this
Agreement and the transactions contemplated hereby and shall duly give notice of, convene and hold a meeting of its shareholders for the purpose of voting on the approval and adoption of this Agreement and shall, through its board of directors,
recommend to its shareholders the approval and adoption of this Agreement. 
 Section 6.03 Blue Sky Laws. Purchaser shall use its
commercially reasonable efforts, and the Company shall use its commercially reasonable efforts to assist Purchaser, to comply with the securities and blue sky laws of all jurisdictions which are applicable to the issuance of the Purchaser Common
Stock in connection with the Merger. The certificates issued by Purchaser hereunder shall be legended as necessary to comply with applicable U.S. federal and state blue sky securities laws and to reflect applicable transfer restrictions. 

ARTICLE VII 
 CONDITIONS PRECEDENT TO OBLIGATIONS OF THE PURCHASER 
 The obligations of the Purchaser under this Agreement are subject to the satisfaction, at or before the Closing, of all the conditions set forth below.

 Section 7.01 Accuracy of Representations and Warranties. All representations and warranties of the Company contained in this
Agreement, any Ancillary Agreement or any other agreement or written statement delivered by the Company to the Purchaser pursuant to this Agreement that are qualified as to materiality will be true and correct in all respects and those not so
qualified shall be true and correct in all material respects on and as of the date of this Agreement. All representations and warranties of the Company contained in this Agreement, any Ancillary Agreement or any other agreement or written statement
delivered by the Company 

  

 44. 

 
to the Purchaser pursuant to this Agreement that are qualified as to materiality will be true and correct in all respects and those not so qualified shall be
true and correct in all material respects on and as of the Closing Date as though such representations and warranties were made on and as of that date, other than inaccuracies in such representations and warranties (which will be subject to
indemnification following the Closing pursuant to Section 9.02) that would not reasonably be expected to (a) cause a Company Material Adverse Effect or (b) result in losses, costs and expenses in excess of $1 million; provided, that
the representations and warranties contained in Section 3.01, the second, third, fourth, fifth, sixth, eleventh and twelfth sentences of Section 3.02, Section 3.03 and Section 3.04(a) shall, if qualified as to materiality, be
true and correct in all respects, and if not so qualified, be true and correct in all material respects. 
 Section 7.02
Performance. The Company will have performed, satisfied and complied in all material respects with all covenants, agreements, and conditions required by this Agreement and the Ancillary Agreements to be performed or complied with by it on or
before the Closing Date. 
 Section 7.03 No Material Adverse Effect. There shall have been no Company Material Adverse Effect
since the date of this Agreement. 
 Section 7.04 Certificates. The Purchaser will have received a certificate, dated the Closing
Date, signed by the Chief Executive Officer of the Company, certifying that the conditions specified in Sections 7.01, 7.02 and 7.03 hereof have been fulfilled in all respects, and a certificate of the Secretary of the Company certifying as to
authorization of the execution, delivery and performance of this Agreement and the Ancillary Agreements. 
 Section 7.05 Absence of
Litigation. No Action by or before any Governmental Authority pertaining to the transactions contemplated by this Agreement or to their consummation will have been instituted or threatened in writing on or before the Closing Date. 
 Section 7.06 Legal Prohibition. On the Closing Date, no Governmental Order shall be in effect prohibiting consummation of the Merger or the
other transactions contemplated hereby or which would make the consummation of such transactions unlawful and no Action shall have been instituted and remain pending before a Governmental Authority to restrain or prohibit the Merger or the other
transactions contemplated by this Agreement and no adverse decision shall have been made by any such Governmental Authority which could materially and adversely affect the Company. No Law shall have been enacted the effect of which would be to
prohibit, restrict, impair or delay the consummation of the Merger or the other transactions contemplated hereby or restrict or impair the ability of the Purchaser to own the Company or the Company to own or conduct its business. 
 Section 7.07 Consents, Approvals, Licenses, etc. All material authorizations, consents, waivers, approvals, orders, registrations,
qualifications, designations, declarations, filings or other action required with or from any Governmental Authority, the consent of all parties to Company Contracts identified on Exhibit 7.07 and all other requirements of Law in connection with the
execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby shall have been duly obtained and shall be reasonably satisfactory to the Purchaser and its counsel. No such consent or approval
(a) shall 

  

 45. 

 
be conditioned on the modification, cancellation or termination of any provision of this Agreement, any Ancillary Agreement or any Company Contract, or
(b) shall impose on the Purchaser or the Company any material condition, provision or requirement with respect to the operation of the Company’s business that is materially more onerous than the conditions imposed upon such operation prior
to Closing, unless the Purchaser gives its prior written approval. 
 Section 7.08 Employment Arrangements. The Purchaser shall
have entered into satisfactory employment arrangements with the individuals identified on Exhibit 7.08, including execution and delivery of the Purchaser’s standard confidentiality, non-compete (to the extent permitted by applicable law)
and invention assignment agreement. 
 Section 7.09 Escrow Agreement. The Shareholder Representative shall have entered into the
Escrow Agreement substantially in the form attached hereto as Exhibit 7.09. 
 Section 7.10 Closing Matters. All
proceedings to be taken by the Company in connection with the consummation of the transactions contemplated hereby and all certificates, opinions, instruments and other documents required to effect the transactions contemplated hereby shall be
reasonably satisfactory in form and substance to the Purchaser and its counsel. 
 Section 7.11 Securities Act Exemption. The
offer and sale of the Purchaser Common Stock to be issued in the Merger shall be exempt from the registration requirements of the Securities Act, as reasonably determined by Purchaser’s counsel. 
 Section 7.12 Opinion. The Purchaser shall have received a legal opinion, dated the Closing Date, from counsel to the Company substantially in
the form attached hereto as Exhibit 7.12. 
 Section 7.13 FIRPTA. The Company shall have delivered a duly executed
certificate in the form specified by Treasury Regulations Section 1.897-2(h). 
 Section 7.14 Shareholder Approval. The
Shareholder Approval of this Agreement, the Merger, the Ancillary Agreements and the transactions contemplated hereby and thereby shall have been obtained in accordance with the CGCL and the Company’s articles of incorporation and by-laws.

 Section 7.15 Resignations. The Company shall have delivered or cause to be delivered to the Purchaser the resignations
effective as of the Closing Date of each of the directors and officers of the Company. 
 Section 7.16 Shareholder Agreement. The
Shareholder Representative, on behalf of the holders of capital stock of the Company, shall have entered into the shareholder agreement substantially in the form attached hereto as Exhibit 7.16 (the “Shareholder
Agreement”). 
 Section 7.17 Registration Rights Agreement. The Shareholder Representative, on behalf of the holders
of capital stock of the Company, shall have entered into the registration rights agreement substantially in the form attached hereto as Exhibit 7.17 (the “Registration Rights Agreement”). 
  

 46. 

 Section 7.18 Dissenting Shares. Holders of no more than seven and one half percent
(7.5%) of the outstanding shares of Company Capital Stock and no Holders of outstanding shares of Company Capital Stock that are Company directors and officers (or affiliates thereof) shall have exercised (or have any continued right to
exercise) appraisal, dissenters’ or similar rights under applicable Law with respect to their shares by virtue of the Merger, which rights shall not have lapsed or been waived. 
 Section 7.19 Financial Condition. The Company shall have no Debt, and shall have cash in excess of its aggregate Transaction Expenses that
have not been paid. 
 Section 7.20 Warrants. The Company shall have given notice of the transactions contemplated by this
Agreement to each holder of a Company Warrant listed on Exhibit 7.20 in accordance with the terms of the applicable Company Warrant. 
 Section 7.21 Existing Shareholder Agreements. The Amended and Restated Voting Agreement, dated as of March 10, 2005, by and among the Company and the other parties thereto and the Amended and Restated Shareholder Rights
Agreement, dated as of March 10, 2005, by and among the Company and the other parties thereto, shall have been terminated. 
 Section 7.22 Success Fee Documentation. The Company and John Kingery shall have entered into a written agreement, in form reasonably satisfactory to the Purchaser, documenting the terms of the Initial Success Fee and True Up
Success Fee and Mr. Kingery’s agreement that payment of the amounts set forth in this Agreement and the Escrow Agreement will satisfy his entitlement to such fees in full, and the board of directors of the Company (including a majority of
independent directors) shall have approved such agreement. 
 ARTICLE VIII 
 CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY 
 The obligations of the Company under this Agreement are subject to the satisfaction, at or before the Closing, of all of the conditions set forth below.

 Section 8.01 Accuracy of Representations and Warranties. All representations and warranties by the Purchaser contained in this
Agreement, any Ancillary Agreement or any other agreement or written statement delivered by the Purchaser to the Company pursuant to this Agreement that are qualified as to materiality will be true and correct in all respects and those not so
qualified will be true and correct in all material respects on and as of the date of this Agreement. All representations and warranties of the Purchaser contained in this Agreement, any Ancillary Agreement or any other agreement or written statement
delivered by the Purchaser to the Company pursuant to this Agreement that are qualified as to materiality will be true and correct in all respects and those not so qualified shall be true and correct in all material respects on and as of the Closing
Date as though such representations and warranties were made on and as of that date, other than inaccuracies in such representations and warranties (which will be subject to indemnification following the Closing pursuant to Section 9.01) that
would not reasonably be expected to (a) cause a Purchaser Material Adverse Effect or (b) result in losses, costs and expenses in excess of $1 million; provided, that the representations and warranties 

  

 47. 

 
contained in Section 4.01, the second, third, fourth and seventh sentences of Section 4.02, Section 4.03 and Section 4.04(a) shall, if
qualified as to materiality, be true and correct in all respects and, if not so qualified, shall be true and correct in all material respects. 
 Section 8.02 Performance. The Purchaser will have performed, satisfied and complied with all covenants, agreements and conditions required by this Agreement and the Ancillary Agreements to be performed or complied with by it on
or before the Closing Date. 
 Section 8.03 No Material Adverse Effect. There shall have been no Purchaser Material Adverse
Effect since the date of this Agreement. 
 Section 8.04 Certification by the Purchaser. The Company will have received a
certificate, dated the Closing Date, signed by the Chief Executive Officer of the Purchaser, on behalf of the Purchaser, certifying that the conditions specified in Sections 8.01, 8.02 and 8.03 hereof have been fulfilled in all respects. 

Section 8.05 Absence of Litigation. No Action by or before any Governmental Authority pertaining to the transactions contemplated by this
Agreement or to their consummation will have been instituted or threatened on or before the Closing Date. 
 Section 8.06 Legal
Prohibition. On the Closing Date, no Governmental Order shall be in effect prohibiting consummation of the Merger or the other transactions contemplated hereby or which would make the consummation of such transactions unlawful and no Action
shall have been instituted and remain pending before a Governmental Authority to restrain or prohibit the Merger or the other transactions contemplated by this Agreement. No Law shall have been enacted the effect of which would be to prohibit,
restrict, impair or delay the consummation of the Merger or the other transactions contemplated hereby. 
 Section 8.07 Shareholder
Approval. The Shareholder Approval of this Agreement, the Merger, the Ancillary Agreements and the transactions contemplated hereby and thereby shall have been obtained in accordance with the CGCL, the Company’s articles of incorporation
and by-laws and the terms of all Company Contracts. 
 Section 8.08 Ancillary Agreements. The Purchaser shall have entered into
the Ancillary Agreements to which it is a party. 
 Section 8.09 Closing Matters. All proceedings to be taken by the Purchaser in
connection with the consummation of the transactions contemplated hereby and all certificates, opinions, instruments and other documents required to effect the transactions contemplated hereby shall be reasonably satisfactory in form and substance
to the Company and its counsel. 
 Section 8.10 Letter Agreement. The Purchaser shall have delivered the Letter Agreement
substantially in the Form attached hereto as Exhibit 8.10. 
  

 48. 

 ARTICLE IX 
 INDEMNIFICATION 
 Section 9.01 Indemnification by the Purchaser.

 (a) Following the Closing the Purchaser shall indemnify, defend and hold harmless the officers, directors, stockholders and
employees of the Company immediately prior to the Effective Time (collectively, the “Company Indemnified Parties”) against, and reimburse any Company Indemnified Party for, any and all losses, damages, Taxes, costs, expenses,
liabilities, obligations and claims of any kind (including in respect of any Action brought by any Governmental Authority or any other Person) including reasonable attorneys’ and consultants’ fees and expenses and other legal costs and
expenses reasonably incurred in prosecution, investigation, remediation, defense or settlement (collectively, “Losses”), that such Company Indemnified Party may at any time suffer or incur, or become subject to, as a result
of or in connection with: 
 (i) the inaccuracy of any representations and warranties made by the Purchaser in this Agreement or any
Ancillary Agreement (without regard to any materiality qualifier contained in such representation or warranty); and 
 (ii) any
failure by the Purchaser to perform any of its covenants or agreements under this Agreement or any of the Ancillary Agreements. 
 (b)
Notwithstanding any other provision in this Agreement to the contrary, the Purchaser shall not be required to indemnify, defend or hold harmless any Company Indemnified Party against or reimburse any Company Indemnified Party for any Losses
pursuant to Section 9.01(a)(i) unless the Shareholder Representative, on behalf of such Company Indemnified Party, has notified the Purchaser in writing in accordance with Section 9.03(a) of a claim with respect to such matters within the
survival period set forth in Section 9.04. 
 (c) Notwithstanding anything herein to the contrary, (i) the Purchaser’s
maximum aggregate liability under Section 9.01(a) shall not exceed an amount equal to (A) number of the shares of Purchaser Common Stock escrowed pursuant to the Escrow Agreement on the Closing Date (less the number of shares equal to
(1) any amount of Losses previously satisfied by Purchaser pursuant to this Section 9.01, divided by (2) the Purchaser Stock Price on the date that each such Loss was satisfied) multiplied by (B) the Purchaser Stock
Price and (ii) all indemnification obligations pursuant to this Section 9.01 may be satisfied, at Purchaser’s election, by the payment of cash or the delivery of additional shares of Purchaser Common Stock (valued at the Purchaser
Stock Price). 
 (d) There shall be no liability pursuant to Section 9.01(a) until such time as the total amount of Losses
pursuant to Section 9.01(a) exceeds $75,000 in the aggregate. If the total amount of Losses pursuant to Section 9.01(a) exceeds $75,000, then the Company Indemnified Parties shall be entitled to be indemnified against all such Losses,
including the first $75,000. 
  

 49. 

 Section 9.02 Indemnification by the Company. 
 (a) Following the Closing the former Holders of securities of the Company, acting through the Shareholder Representative, shall indemnify, defend
and hold harmless the Purchaser, its Subsidiaries and their respective employees, officers, directors and stockholders (collectively, the “Purchaser Indemnified Parties”) against, and reimburse any Purchaser Indemnified Party
for, any and all Losses that such Purchaser Indemnified Party may at any time suffer or incur, or become subject to, as a result of or in connection with: 
 (i) the inaccuracy of any representations and warranties made by the Company in this Agreement or any Ancillary Agreement (without regard to any materiality qualifier contained in such representation and
warranty); 
 (ii) any failure by the Company to perform any of its covenants or agreements under this Agreement or any of the
Ancillary Agreements; 
 (iii) any payments made to holders of Dissenting Shares in excess of $22.29 for each Dissenting Share and
all related bona-fide out-of-pocket costs and expenses of the Purchaser in connection with the exercise of dissent or appraisal rights by holders of Dissenting Shares; and 
 (iv) all Taxes with respect to any Pre-Closing Period or Pre-Closing Partial Period. 
 (b) Notwithstanding any other provision in this Agreement to the contrary, the former Holders of securities of the Company, acting through the
Shareholder Representative, shall not be required to indemnify, defend or hold harmless any Purchaser Indemnified Party against or reimburse any Purchaser Indemnified Party for any Losses pursuant to Section 9.02(a) unless such Purchaser
Indemnified Party has notified the Shareholder Representative in writing in accordance with Section 9.03(a) of a claim with respect to such matters within the survival period for representations and warranties set forth in Section 9.04.

 (c) Subject to Section 9.05, (i) the Escrow Fund shall be the sole source of recovery of any Purchaser Indemnified Party
following the Closing and (ii) all indemnification obligations pursuant to this Section 9.02 shall be satisfied solely by the forfeiture of shares of Purchaser Common Stock deposited in the Escrow Fund, which shares shall be valued for
this purpose at the Purchaser Stock Price. 
 (d) Except for claims pursuant to the last sentence of Section 2.09 and
Section 9.02(e), there shall be no liability pursuant to Section 9.02(a)(i) and Section 9.02(a)(ii) until such time as the total amount of Losses pursuant to Section 9.02(a)(i) and Section 9.02(a)(ii) exceeds $75,000 in the
aggregate. If the total amount of Losses pursuant to Section 9.02(a)(i) and Section 9.02(a)(ii) exceeds $75,000, then the Purchaser Indemnified Parties shall be entitled to be indemnified against all such Losses, including the first
$75,000. 
 (e) Following the satisfaction of all properly asserted claims for Losses pursuant to Section 9.02(a) (and the
expiration of time to bring any new claims for Losses pursuant to Section 9.02(a)) but prior to the release of any amounts remaining in the Escrow 

  

 50. 

 
Fund to the former Holders of securities of the Company, the former Holders of securities of the Company, acting through the Shareholder Representative,
shall cause to be paid to John Kingery a true up success fee (the “True Up Success Fee”) if any such True Up Success Fee is then owing to John Kingery as calculated in accordance with Section 9.02(f). The Escrow Fund shall be the sole
source of payment of the True Up Success Fee and the True Up Success Fee shall be satisfied solely by the forfeiture of shares of Purchaser Common Stock deposited in the Escrow Fund, which shares shall be valued for this purpose at the True Up Share
Price as defined in Section 9.02(f). 
 (f) The True Up Success Fee shall be payable in the event that the value of the Purchaser
Common Stock received by John Kingery in accordance with Section 2.06 hereof upon the consummation of the Merger exceeds $22.29 per share on the day that is fifteen (15) months from the Closing Date (as adjusted for any stock dividends,
combinations, splits, recapitalizations and the like after the date hereof) (such higher per share value, the “True Up Share Price”). In the event that the Purchaser is acquired or engages in a similar transaction or series of transactions
after the date hereof resulting in no Purchaser Common Stock being outstanding on the date that the True Up Success Fee is calculated and paid, the value of one share of Purchaser Common Stock for purposes of calculating the True Up Success Fee
shall refer to the current value of the consideration received for one share of Purchaser Common Stock in connection with such acquisition or similar transaction or series of transactions. The value of the True Up Success Fee shall be determined by
calculating the value of the Merger Consideration using the True Up Share Price (the “True Up Merger Consideration”) instead of $22.29. Mr. Kingery shall be entitled to 1.5% of the value of the of the True Up Merger Consideration for
the first $15,000,000 of True Up Merger Consideration and 3% of the value of the True Up Merger Consideration in excess of $15,000,000 less (i) any amounts previously received as payment of the Initial Success Fee (valuing such shares received
as payment of the Initial Success Fee at the True Up Share Price) and (ii) the value of any amounts in the Escrow Fund payable to Mr. Kingery on account of the issuance of the Initial Success Fee. For purposes of this Section 9.02(f),
the term “Initial Success Fee” refers to the shares of Purchaser Common Stock received by Mr. Kingery upon consummation of the Merger on account of shares of Company Common Stock received by Mr. Kingery after the date hereof and
prior to the consummation of the Merger for compensatory purposes. 
 (g) Notwithstanding anything in this Agreement or the Escrow
Agreement to the contrary, the calculation and payment of the True Up Success Fee shall be the sole responsibility of the Holders acting through the Shareholder Representative, and neither the Company nor the Purchaser or Merger Sub shall have any
responsibility or liability with respect to the calculation or payment of the True Up Success fee pursuant to Sections 9.02(e) or 9.02(f) hereof or the Escrow Agreement. 
 Section 9.03 Notification of Claims. 
 (a) The Shareholder Representative, in the case of
indemnification pursuant to Section 9.01, and the Purchaser, in the case of indemnification pursuant to Section 9.02 (the “Indemnified Party”) shall promptly notify the Purchaser, in the case of indemnification
pursuant to Section 9.01, or the Shareholder Representative, in the case of indemnification pursuant to Section 9.02 (the “Indemnifying Party”), in writing of any pending or threatened 

  

 51. 

 
claim or demand which the Indemnified Party has determined has given or could give rise to a right of indemnification under this Agreement (including a
pending or threatened claim or demand asserted by a third party), describing in reasonable detail, to the extent known by the Indemnified Party, the facts and circumstances with respect to the subject matter of such claim or demand; provided,
however, that the failure to provide such notice shall not release the Indemnifying Party from any of its obligations under this Article IX except and only to the extent the Indemnifying Party is prejudiced by such failure. Any such notice must
be made to the Indemnifying Party not later than the expiration of the survival period specified in Section 9.04 below. If the Indemnifying Party does not notify the Indemnified Party within 30 days following its receipt of such notice that the
Indemnifying Party disputes its liability to the Indemnified Party under this Article IX, such claim specified by the Indemnified Party in such notice shall be conclusively deemed a liability of the Indemnifying Party under this Article IX and the
Indemnifying Party shall pay the amount of such claim to the Indemnified Party on demand or, in the case of any notice in which the amount of the claim (or any portion thereof) is estimated, on such later date when the amount of such claim (or such
portion thereof) becomes finally determined. If the Indemnifying Party has timely disputed its liability with respect to such claim, as provided above, and such claim is not a Third Party Claim, the Indemnifying Party and the Indemnified Party shall
proceed in good faith to negotiate a resolution of such dispute. If the Indemnifying Party and the Indemnified Party are not able to resolve such dispute within 30 days (the “Dispute Resolution Period”), such dispute shall
promptly be submitted to arbitration in New York City before the American Arbitration Association (the “AAA”) in accordance with the commercial arbitration rules of the AAA. The arbitration tribunal shall be composed of three
arbitrators, one of which shall be appointed by the Purchaser within 10 Business Days of the end of the Dispute Resolution Period, one of which shall be appointed by the Shareholder Representative within 10 Business Days of the end of the Dispute
Resolution Period, and the third shall be appointed by the other two arbitrators; provided that if the dispute involves Losses that do not exceed $1 million, the arbitration tribunal shall be composed of one arbitrator mutually appointed by
both the Purchaser and the Shareholder Representative. The arbitration tribunal will be directed to resolve such dispute, disagreement or controversy, and their resolution shall be binding on the Purchaser, the Shareholder Representative and all
Purchaser Indemnified Parties or Company Indemnified Parties. 
 (b) If the Indemnified Party shall notify the Indemnifying Party of
any claim or demand pursuant to Section 9.03(a) which relates to a pending or threatened claim or demand asserted by a third party (a “Third Party Claim”), the Purchaser shall have the right to defend such claim or
demand with counsel of its choice (provided that such counsel shall be reasonably acceptable to the Shareholder Representative if the claim is subject to indemnification pursuant to Section 9.01). The Purchaser and the Shareholder
Representative will fully cooperate in any such action, and shall make available to each other any books or records useful for the defense of any such claim or proceeding. Subject to the foregoing, (i) the Indemnified Party shall not settle or
compromise any such Third Party Claim without the prior written consent of the Indemnifying Party and (ii) the Indemnifying Party shall not settle or compromise any such Third Party Claim without the prior written consent of the Indemnified
Party, in each case of (i) and (ii) which consent shall not be unreasonably withheld, delayed or conditioned. 
 Section 9.04 Survival of Representations and Warranties. All of the representations and warranties contained in this Agreement shall survive the Closing hereunder and continue in 

  

 52. 

 
full force and effect for a period of fifteen (15) months thereafter, regardless of any investigation made by the Purchaser or the Company or on their
behalf, except as to any matters with respect to which notice of a bona fide written claim shall have been made pursuant to Section 9.03 before such date, in which event survival shall continue (but only with respect to, and to the extent of,
such claim) until the final resolution of such claim or action, including all applicable periods for appeal. 
 Section 9.05 Other
Indemnification Provisions. The remedies provided herein shall be the exclusive remedies of each of the parties hereto with respect to any Losses arising out of the transactions contemplated hereby; provided, however, that (a) the
parties hereto shall be entitled to an injunction or other equitable relief to prevent breaches of this Agreement, to enforce specifically the terms and provisions of this Agreement or to seek any other remedy to which they are entitled in equity;
and (b) nothing herein shall limit any rights or remedies (i) under the indemnification provisions of any Letter of Transmittal, (ii) for claims of fraud in connection with statements or omissions in this Agreement, (iii) which,
as a matter of applicable Law, cannot be limited or waived or (iv) which any party may have under any Ancillary Agreement (other than the Escrow Agreement) or any employment agreement or similar arrangement. 
 Section 9.06 Tax Treatment of Indemnification Payments. Any payment made pursuant to this Article IX shall be treated as an adjustment to the
Merger Consideration for federal, state and local income Tax purposes unless a contrary treatment is required under applicable Law. Notwithstanding the foregoing, if any payment made pursuant to this Article IX (including, without limitation, this
Section 9.06) is determined to be taxable to the party receiving such payment by any Governmental Authority, the paying party shall also indemnify the party receiving such payment for any Taxes incurred by reason of receipt of such payment
(taking into account any actual reduction in Tax liability to the receiving party) and any Losses incurred by the party receiving such payment in connection with such Taxes (or any asserted deficiency, claim, demand, action, suit, proceeding,
judgment or assessment, including the defense or settlement thereof, relating to such Taxes). 
 ARTICLE X 
 TERMINATION 
 Section 10.01 Termination of Agreement. The parties may terminate this Agreement as provided below: 
 (a) The
Purchaser and the Company may terminate this Agreement by mutual written consent at any time prior to the Closing; 
 (b) The
Purchaser may terminate this Agreement by giving written notice to the Company at any time prior to the Closing (i) in the event the Company has breached any representation, warranty or covenant contained in this Agreement in any respect (in
the case of any representation or warranty qualified by materiality) or in any material respect (in the case of any representation or warranty without any materiality qualification), and such breach would reasonably be expected to cause a Company
Material Adverse Effect, the Purchaser has notified 

  

 53. 

 
the Company of the breach, and the breach has continued without cure for a period of five (5) days after the notice of breach or (ii) if the
Closing shall not have occurred on or before April 30, 2008, other than through a failure of the Purchaser to fulfill its obligations hereunder; 
 (c) The Purchaser may terminate this Agreement by giving written notice to the Company if at any time prior to the Closing (i) the Company’s board of directors has withdrawn or modified, or proposed
to withdraw or modify, in a manner adverse to Purchaser, its approval or recommendation of this Agreement, the Merger or the transactions contemplated hereby or (ii) there shall have been a material breach by any stockholder of the Company of
its representations, warranties and covenants contained in the Voting Agreement; or 
 (d) The Company may terminate this Agreement by
giving written notice to the Purchaser at any time prior to the Closing (i) in the event the Purchaser has breached any representation, warranty or covenant contained in this Agreement in any respect (in the case of any representation or
warranty qualified by materiality) or in any material respect (in the case of any representation or warranty without a materiality qualifier), and such breach would reasonably be expected to cause a Purchaser Material Adverse Effect, the Company has
notified the Purchaser of the breach, and the breach has continued without cure for a period of five (5) days after the notice of breach or (ii) if the Closing shall not have occurred on or before April 30, 2008, other than through a
failure of the Company to fulfill its obligations hereunder. 
 Section 10.02 Effect of Termination. In the event of termination
of this Agreement as provided in Section 10.01 hereof, (a) each party shall return all documents, work papers and other material of any other party provided by such other party in connection with this Agreement and the proposed Merger,
whether provided before or after the execution hereof (except that each party’s counsel shall be entitled to retain one copy of any such documents, work papers and other materials in order to determine compliance with the terms of this
Agreement) and (b) this Agreement shall forthwith become void and there shall be no liability or obligation on the part of Purchaser, Merger Sub, the Company or their respective officers, directors, employees, stockholder or representatives (in
their respective capacities as such); provided, that each party hereto shall remain liable for any breach of this Agreement prior to its termination. 
 ARTICLE XI 
 GENERAL PROVISIONS 
 Section 11.01 Effect of Due Diligence. No investigation by or on behalf of the Purchaser into the business, operations, prospects, assets or
condition (financial or otherwise) of the Company shall diminish in any way the effect of any representations or warranties made by the Company in this Agreement or shall relieve the Company of any of its obligations under this Agreement. No
investigation by or on behalf of the Company into the business, operations, prospects, assets or condition (financial or otherwise) of the Purchaser shall diminish in any way the effect of any representations or warranties made by the Purchaser in
this Agreement or shall relieve the Purchaser of any of its obligations under this Agreement. 
 Section 11.02 Expenses. Except
as may be otherwise specified herein, all costs and expenses, including fees and disbursements of counsel, financial advisors and accountants, 

  

 54. 

 
incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses, whether or
not the Closing shall have occurred; provided, however, that in the event that this Agreement is terminated pursuant to any provision of Article X other than Section 10.01(b)(i) or 10.01(c), the Purchaser shall pay all fees of the
Company’s auditors incurred in connection with the transactions contemplated hereby. 
 Section 11.03 Notices. All notices,
requests, claims, demands and other communications hereunder shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service, by facsimile
(followed by delivery of a copy via overnight courier service) or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such other address for a party as shall be
specified in a notice given in accordance with this Section 11.03): 
  

	 	(a)	if to the Company: 

 Fast Track Systems, Inc.

 20 Ash Street 
 Millennium 1,
Suite 330 
 Conshohocken, PA 19428 
 Telecopier:                      
 Attention: Ed Seguine 
 with a copy to (which shall not constitute notice): 
 Cooley Godward Kronish LLP 
 101 California Street, 5th Floor 
 San Francisco, CA 94111-5800 
 Facsimile: (415) 693-2222 
 Attention:
Craig Jacoby 
  

	 	(b)	if to the Purchaser: 

 Medidata Solutions, Inc.

 79 Fifth Avenue 
 New York,
NY 10003 
 Telecopier: (212) 466-4177 
 Attention: Michael I. Otner 
 with a copy to (which shall not constitute notice): 
 Fulbright & Jaworski L.L.P. 
 666
Fifth Avenue 
 New York, New York 10103 
 Attention: Paul Jacobs, Esq. 
 Telecopier: (212) 318-3400 
  

 55. 

	 	(c)	if to the Shareholder Representative: 

 Shareholder
Representative Services LLC 
 999 18th Street, Suite 1825 
 Denver, CO 80202 
 Fax No.: (720) 306-3015 
 Email: support@shareholderrep.com 
 Attention: Managing Director 
 Section 11.04 Headings. The headings contained in this Agreement are for reference
purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 
 Section 11.05 Severability. If
any term or other provision of this Agreement is held invalid, illegal or incapable of being enforced by any Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as
the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally
contemplated to the greatest extent possible. 
 Section 11.06 Entire Agreement. This Agreement and the Ancillary Agreements
constitute the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and supersede all prior and contemporaneous agreements and undertakings, both written and oral, between the parties with respect to the
subject matter hereof, including that certain letter agreement between Purchaser and the Company dated January 3, 2008, as amended. 
 Section 11.07 Assignment. This Agreement shall not be assigned by any party hereto, by operation of Law or otherwise, without the prior written consent of the other parties, and any such attempted assignment shall be void and of
no force or effect. 
 Section 11.08 No Third-Party Beneficiaries. Except as provided in Article IX, this Agreement is for the
sole benefit of the parties hereto and their permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever. 
 Section 11.09 Amendment, Waiver. None of the terms or provisions hereof may be amended, supplemented, waived or changed except by a writing
signed by the parties hereto. No delay or failure on the part of any party in exercising any right hereunder, and no partial or single exercise thereof, will constitute a waiver of such right or of any other right hereunder. 
 Section 11.10 Governing Law; Submission to Jurisdiction, Waivers. 
 (a) Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to
principles of conflict of laws that would result in the application of the laws of another jurisdiction. The parties hereto hereby irrevocably submit to the exclusive jurisdiction of any federal or state court located in 

  

 56. 

 
New York County, New York over any dispute arising out of or relating to this Agreement or any of the transactions contemplated hereby and each party hereby
irrevocably agrees that all claims in respect of such dispute or any suit, action or proceeding related thereto may be heard and determined in such courts. The parties hereby irrevocably waive, to the fullest extent permitted by Applicable Law,
(i) any objection which they may now or hereafter have to the laying of venue of any such dispute brought in such court or any defense of inconvenient forum for the maintenance of such dispute and (ii) the right to a trial by jury in any
action or proceeding arising out of the transactions contemplated by this Agreement, regardless of which party initiates any such action or proceeding. Each of the parties hereto agrees that a judgment in any such dispute may be enforced in other
jurisdictions by suit on the judgment or in any other manner provided by law. Each of the parties hereto hereby consents to process being served by any party to this Agreement in any suit, action or proceeding by the mailing of a copy thereof in
accordance with the provisions of Section 11.03. 
 Section 11.11 Counterparts. This Agreement may be executed in one or
more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed
counterpart of a signature page to this Agreement by telecopier or pdf shall be effective as delivery of a manually executed counterpart of this Agreement. 
 Section 11.12 Construction. The parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement
shall be construed as if drafted jointly by the parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. Any reference to any federal, state,
local, or foreign Law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The parties intend that each representation, warranty and covenant contained herein shall have
independent significance. If any party has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of
the relative levels of specificity) which the party has not breached shall not detract from or mitigate the fact that the party is in breach of the first representation, warranty or covenant. 
 Section 11.13 Specific Performance. Each party acknowledges and agrees that the other party would be damaged irreparably in the event any of
the provisions of this Agreement are not performed in accordance with their specific terms or otherwise are breached. Accordingly, each party agrees that the other party shall be entitled to an injunction or injunctions to prevent breaches of the
provisions of this Agreement and to enforce specifically this Agreement and the terms and provisions hereof in any action instituted in any court of the United States or any state thereof having jurisdiction over the parties and the matter, in
addition to any other remedy to which they may be entitled, at law or in equity. 
 [THE REMAINDER
OF THIS PAGE IS INTENTIONALLY LEFT BLANK.] 
  

 57. 

 IN WITNESS WHEREOF, the Purchaser, Merger Sub, the
Company and the Stockholder Representative have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the date first written above. 
  

			
	MEDIDATA SOLUTIONS, INC.
		
	By:	 	 /s/ Tarek Sherif

	Name:	 	Tarek Sherif
	Title:	 	President and CEO
	
	FT ACQUISITION CORP.
		
	By:	 	 /s/ Tarek Sherif

	Name:	 	Tarek Sherif
	Title:	 	President
	
	FAST TRACK SYSTEMS, INC.
		
	By:	 	 /s/ Edward S. Seguine

	Name:	 	Edward S. Seguine
	Title:	 	CEO
	
	SHAREHOLDER REPRESENTATIVE SERVICES LLC
		
	By:	 	 /s/ W. Paul Koenig

	Name:	 	W. Paul Koenig
	Title:	 	Manager

  

 58.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]